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Preface
This dissertation is organized into three chapters, roughly encompassing a literature 
review of neurogenesis mechanisms in Drosophila melanogaster (and other model 
organisms), our work to characterize neural fate patterning in the type II neuroblast 
lineages of Drosophila, and an overview of the state of the field in single-cell -omics 
experimental design and analysis, the latter of which I expand upon greatly. As such, it 
covers a range of topics in the rapidly developing single-cell ‘-omics’ field, and I aim to 
be up-to-date in my descriptions therein at the time of writing. However, even as this 
field has drastically changed even over the course of my own PhD research, shifts in 
best practices for experimental design and analysis should be expected in the future as 
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Abstract
The Drosophila type-II neuroblast lineages present an attractive model to investigate the
neurogenesis and differentiation process as they adapt to a process similar to that in the
human outer subventricular zone. Here, I performed targeted single-cell mRNA 
sequencing in third instar larval brains to study this process of the type-II neuroblast 
lineages. Combining prior knowledge, in silico analyses, and in situ validation, my multi-
informatic investigation describes the molecular landscape from a single developmental 
snapshot. 17 markers are identified to differentiate distinct maturation stages. 30 
markers are identified to specify the stem cell origin and/or cell division numbers of 
INPs, and at least 12 neuronal subtypes are identified. To foster future discoveries, I 
developed MiCV, a web tool for rapidly and interactively analyzing scRNA-seq datasets.
Taken together, these resources majorly advance our understanding of the neural 
differentiation process at the molecular level.
xiii
Chapter 1
Introduction: The Evolutionary Scaling of Neurogenesis During Development
Model organisms and their brains
As organisms with nervous systems have evolved over time to become more well-suited
to their environments, the complexity and scale of their nervous systems have evolved 
along with them. However the relationships between organism size, nervous system 
complexity, and cognitive ability are challenging to describe and understand. For 
instance C. elegans (the worm), with only 302 neurons in the hermaphrodite (Hobert, 
2010), is capable of sensing a range of external stimuli, including temperature, 
pheromones, attractive/repellent odors, and other chemicals, synthesizing these stimuli 
and engaging in complex locomotive and mating behaviours in response to them (Barr 
and Garcia, 2006; Tsalik and Hobert, 2003). Drosophila melanogaster (the fruit fly), on 
the other hand, has nearly 100,000 neurons in its adult brain (Chiang et al., 2011; 
Scheffer et al., 2020). This more than 300X increase in scale over the worm imparts 
some of the added stimulus sensitivity and behavioral complexity observed in the fruit 
fly. Likewise, vertebrates such as Mus musculus (mice) and Homo sapiens (humans) 
have developed central brains with 71 million (Keller et al., 2018) and 86 billion 
(Herculano-Houzel, 2012) neurons respectively, in order to facilitate ever more complex 
sensory, behavioral, and higher-order cognitive functions. 
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Fig. 1.1: The evolutionary scaling of neurogenesis
Abridged phylogenetic tree (Letunic and Bork, 2021) showing evolutionary lineage 
relationships between 4 selected model organisms and humans. The number of 
neurons in adults of each species grows dramatically across evolution, indicated in part 
by the relative scaling factor (#X) of the number of neurons in each organism vs. C. 
elegans, a relatively simple benchmark organism.
Neurogenesis mechanisms employed across model organisms
A variety of neurogenesis mechanisms have evolved in order to facilitate neurogenesis 
on these vastly varying scales. Some organisms, such as C. elegans, largely employ 
direct neurogenesis, whereby a neural stem cell divides and births a cell that will mature
and take on a neural fate without dividing again (Hobert, 2010; White et al., 1986). 
Though this is perhaps the simplest mechanism possible for generating neurons during 
development, such a 1-to-1 pairing of neural stem cells to neurons does not scale well 
to larger nervous systems. 
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Fig. 1.2: Three common neurogenesis mechanisms
Cell division products are shown at the ends of arrows, with self-directed arrows 
indicating self-renewal of the mother cell. Common names of important cell types are 
provided in bold. Names of these cells in the developing Drosophila central nervous 
system are provided in parenthesis. The type I neuroblasts in Drosophila predominantly 
employ indirect neurogenesis and are far more numerous (approximately 100 in each 
brain lobe) than the type II neuroblasts, which employ neurogenesis via intermediate 
progenitors and are more scarce (8 in each brain lobe). 
More complex organisms, such as Drosophila melanogaster, begin to predominantly 
employ a more complex indirect neurogenesis mechanism, whereby a neural stem cell 
divides and births a precursor cell (in Drosophila, this is termed a Ganglion Mother Cell 
or GMC) (Boone and Doe, 2008; Doe, 1992; Matsuzaki et al., 1992). This precursor will 
mature and divide exactly one more time, giving rise to two daughter neurons/glia, 
depending primarily on the neural stem cell’s age and lineage identity (Homem and 
Knoblich, 2012). This now 1-to-2 pairing of neural stem cells to neurons may scale 
better for larger nervous systems, but is still linearly dependent upon the number of 
neural stem cells present during development and thus poses challenges for organisms 
whose nervous systems are nearly 285 million times as large as that of C. elegans.
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In order to break beyond this linear relationship, organisms have developed neural stem
cells that generate progenitors that can divide multiple times before terminally 
differentiating. These intermediate progenitor cells (intermediate neural 
progenitors/INPs in Drosophila (Boone and Doe, 2008), outer radial glia cells/oRGCs in 
the mouse/human (Hansen et al., 2010; Wang et al., 2011)) maintain their stemness 
without becoming tumorigenic through a combination of genetic (Bayraktar et al., 2010; 
Janssens et al., 2014) and metabolic (Bonnay et al., 2020) controls, and can generate 
many precursor cells throughout their lifetime. Effectively, the use of intermediate neural
progenitors enables an exponential increase in the size of any given neural stem cell’s 
neural progeny. 
Progenitor patterning as a mechanism for neural fate specification
Regardless of organism size and complexity (at least across the organisms discussed 
here in this work), neurons generated during development are not identical clones of 
one another, but rather adopt a variety of unique molecular, morphological, connetomic,
and electrophysiological characteristics (Kepecs and Fishell, 2014). Though these 
characteristics are not necessarily independent of one another, the combination of 
these and other observable neural characteristics allows us to define a ‘neural subtype’ 
or ‘neural fate’ for each neuron, and subsequently allows us to ask the question “What 
factors led to this specific neuron acquiring this specific neural fate during 
development?” 
A variety of factors play a role in neural fate specification. At a high level, neural stem 
cell identity (i.e. which mother cell did this neuron come from?) and developmental time 
(i.e. how many cell division cycles has this neuron’s mother cell gone through prior to 
this neuron’s birth?) have both been observed to play a role in neural fate specification 
across different organisms (Homem and Knoblich, 2012; Jessell, 2000; Li et al., 2013; 
Nadadhur et al., 2018; Sulston, 1983). It is generally understood that these two factors 
impart specific neural fates on their progeny in part via the expression of unique 
combinations of transcription factors that vary across space and developmental time. 
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Fig. 1.3: A naive view of neural fate patterning 
Simple neurogenesis mechanisms such as direct and indirect (pictured here) 
neurogenesis yield a 1-to-1 or 1-to-2 pairing of neurons to neural stem cells (NSCs). As 
these NSCs age and undergo cell division cycles, the temporally varying transcription 
factors they express change, patterning their neural progeny and ultimately defining 
their neural fate. Color here indicates the molecularly-defined fate/state of each cell, 
changing based primarily on the NSC’s cell division number. Note that absolute 
developmental time is not to scale in this figure. 
When considering neurogenesis via intermediate neural progenitors, we must also 
consider a third high-level factor - the age of a specific progenitor cell/the number of cell
division cycles a specific progenitor cell has undergone before birthing a given neuron. 
As neural stem cells age and express a variety of neural patterning factors, so to do 
intermediate progenitors age, expressing their own cascade of temporally varying 
transcription factors that pattern their neural progeny (Bayraktar and Doe, 2013; Wang 
et al., 2014) in a combinatorial fashion with neural stem cell age and lineage identity. 
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Fig. 1.4: A more complete view of neural fate patterning
Neurogenesis via intermediate neural progenitors enables massive neural diversity by 
intersecting the fate patterning mechanisms of the neural stem cell (NSC) cell division 
number with that of their daughter intermediate neural progenitors’ (INP) cell division 
cycles. As NSCs age/divide, they birth progenitors that are patterned with the NSC’s 
temporally varying transcription factors. INPs likewise birth precursor cells that are 
patterned both by the NSC’s and INP’s independent temporally varying transcription 
factors, making up a combinatorial neural fate patterning code. Color here indicates the 
molecularly-defined fate/state of each cell, changing based primarily on the INP’s cell 
division number. Note that absolute developmental time is not to scale in this figure. 
Additionally, extracellularly expressed spatial patterning cues can induce 
axonal/dendritic targeting programs that specify a neuron’s connectomic fate (Ming et 
al., 2002; Sanes and Lichtman, 2001). However, this fate specification mechanism 
generally relies on cells exclusive of a given neuron’s lineage (i.e. neurons may be 
induced to migrate towards/form connections with neurons far away from their mother 
stem cell lineage). Though not the focus of this work, this mechanism is undoubtedly 
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part of the broader neural fate specification process, further increasing its complexity.
Drosophila melanogaster as a model for vertebrate neurogenesis
Drosophila melanogaster represents a model organism that recapitulates many features
of vertebrate neurogenesis. Unlike the abundant type-I neuroblasts (NB, neural stem 
cells), the 16 type II NBs in the Drosophila brain adopt a neurogenesis process that is 
directly analogous to that observed in mammalian cortical development (Homem and 
Knoblich, 2012). During development, each type II NB undergoes repeated asymmetric 
cell divisions to generate an NB and a sibling progeny that acquires a progenitor identity
(i.e. intermediate neural progenitor, INP). Each INP undergoes limited rounds of 
asymmetric cell division to re-generate and to produce a ganglion mother cell (GMC), 
which divides once more to become two neuron(s) and/or glial cell(s). Along this NB-
INP-GMC-neuron maturation process, cells express a well-defined cascade of 
transcription factors that mark these cell differentiation stages (Ren et al., 2017; Syed et
al., 2017). In parallel, INPs born in each division cycle may express a cascade of 
transcription factors unique to each NB lineage that contribute to the generation of 
different neural progenies (Bayraktar and Doe, 2013). It is highly plausible that the 
combination of these two transcription factor cascades alongside a third molecular axis, 
which defines unique NBs (i.e., each NB generates a distinct lineage), brings about the 
generation of a highly diverse neuronal pool.
Characterization of temporally varying molecular factors that pattern intermediate
neural progenitors and their progeny
Previous work that revealed the existence of temporally varying patterning mechanisms 
in the Drosophila type II NB lineages relied heavily on in situ antibody screening 
experiments, whereby tissues are stained by a library of antibodies that may or may not 
be expressed in the cell lineages of interest. Because the type II NB progenies typically 
do not migrate during the larval stages of development, there exists a spatial 
relationship between the mother NB, her daughter INPs, and their daughter 
GMCs/neurons/glia - essentially, as the NB divides, its daughter INP pushes previously 
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born cells further from the mother NB, and likewise for the INP progenies. In this way, 
when screening many antibodies at a single point in developmental time, the spatial 
localization of the antibody signal with respect to the mother NB and INPs gives clues 
as to the temporal expression dynamics of the protein of interest (Bayraktar and Doe, 
2013; Bayraktar et al., 2010). Putative temporally varying genes can be further 
interrogated for functional importance in Drosophila by utilizing the wide range of 
genetic tools made available by the Drosophila research community, most notably the 
many RNAi lines (Perkins et al., 2015) that can, under proper genetic control, knock-
down expression of single genes at the mRNA level in specific sub-populations of cells. 
This combination of tools was most famously (in this context) used by Bayraktar and 
Doe in their 2013 Nature paper, wherein they described the Dichaete (D), grainy-head 
(grh), eyeless (ey) temporally varying transcription factor expression pattern in the type 
II NBs. They show that as INPs are born they typically express D and birth neural 
progeny expressing bsh and/or D. As they mature, these INPs stop expressing D and 
begin to express grh and eventually ey, birthing unique neural progeny at each stage of 
this INP aging process. They functionally validate the necessity of these genes for 
generating these neural progeny, and further characterize the in situ expression of 52 
genes using their antibody library, identifying which (if any) type II NB lineages express 
these genes at the NB, INP, or neural progeny level.
Studies with similar sets of tools have been performed in the developing murine neural 
crest by many groups in order to address similar questions of neural fate specification 
(Simões-Costa and Bronner, 2015) in this much more complex organism. Marker genes
that identify key neural fates/progenitor patterning mechanisms have certainly been 
identified, though the central question still remains: how many genes/gene transitions 
are needed to fully specify each neural fate in a single neural stem cell lineage? 
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The need for high-throughput molecular screens for more complete 
characterization of temporally varying neurogenesis mechanisms
Despite the massive significance of previous studies in this space, their reliance on 
antibody libraries limits their scope. Drosophila melanogaster has a genome with more 
than 14,000 protein-coding genes, at least 700 of which exhibit transcription factor 
activities (Shokri et al., 2019). Though direct-screening techniques are powerful, the 
advent of high throughput single-cell mRNA sequencing (scRNA-seq) technologies has 
enabled researchers to much more broadly investigate the mRNA expression landscape
of hundreds of thousands of cells (Macosko et al., 2015; Ziegenhain et al., 2017). 
Coupled with a vast array of analytical tools that enable us to take these high-
dimensional datasets and identify significant molecular signatures from them (Butler et 
al., 2018; Wolf et al., 2018), researchers can make hypotheses about the number of 
unique cellular subtypes in the brain (Cocanougher et al., 2019; Saunders et al., 2018), 
what the functions of these subtypes might be (Ren et al., 2019), and what subtypes 
might arise together along a common developmental pathway (Cao et al., 2019; Qiu et 
al., 2017; Soldatov et al., 2019). This combination of experimental and analytical 
advances has removed the need to rely solely on limited and biased single-molecule 
screens, instead enabling experiments to yield information about the near-complete 
mRNA expression landscape of thousands of cells at a time without the need for prior 
knowledge about/reagents for probing specific genes of interest.
Leveraging genetic tools to improve high-throughput scRNA-seq sensitivity 
The most ‘straightforward’ scRNA-seq experimental setup traditionally might involve a 
researcher collecting a tissue of interest (for example, the whole larval Drosophila 
brain), chemically and mechanically dissociating it into a viable single-cell suspension, 
and finally processing this entire single-cell suspension using one of many different 
scRNA-seq mRNA capture techniques; commonly 10X Chromium, DropSeq (Macosko 
et al., 2015), SeqWell (Gierahn et al., 2017), Smart-seq (Hagemann-Jensen et al., 
2020; Picelli et al., 2014), and inDrops (Klein et al., 2015; Lan et al., 2016), though 
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many other techniques have been and are being developed to accomplish the central 
goal of capturing and barcoding poly-adenlyated mRNA transcripts from many cells in 
parallel. I refer to this experimental setup as a “cell atlas” style of scRNA-seq 
experiment, where a tissue of interest is used in an unbiased manner to characterize 
(‘build an atlas of’) molecular profiles of cells within that tissue. These studies are broad 
in their scope and reveal an incredible amount of cell type heterogeneity irrespective of 
tissue type (see, for example, (Allen et al., 2020; Cao et al., 2019; Cocanougher et al., 
2019)).
While “cell atlas” style scRNA-seq datasets effectively characterize the transcriptomes 
of the majority of cells from a region of interest, cell populations that are classically 
clustered together (through in situ and/or functional analyses, for example) may not be 
identified by blind in silico cluster analysis (Kiselev et al., 2019). In addition, broad 
scRNA-seq studies often do not take advantage of the extensive collection of genetic 
labelling tools that can highlight classically clustered cell populations, enabling them to 
be studied in greater detail at far lower cost. For instance, a targeted approach to 
scRNA-seq is required if we are to confidently and efficiently describe nuanced 
developmental systems, such as the specification of unique neural subtypes derived 
from the type-II NB lineages of Drosophila, where inclusion of non-type-II derived cells 
(making up the majority of the fly brain) would introduce overwhelming noise and 
confound our analysis, or require an enormous increase in experimental scale and cost.
In order to focus on specific cell populations of interest (for instance, in this work, the 
Drosophila type II NBs and their progeny), transgenic tools such as the UAS-Gal4 
(Brand and Perrimon, 1993) system in Drosophila and the Cre-lox (Orban et al., 1992) 
system in mice and other vertebrates can be used to fluorescently label cells that 
express genes under the control of specific promoter/enhancer sequences. Drosophila 
melanogaster has a famously large library of Gal4 driver lines generated by the 
research community over the past 3 decades, with more than 7945 Gal4 lines available 
from the US-based Bloomington Drosophila Stock Center alone (Indiana University, 
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Bloomington Indiana, USA). Each of these Gal4 driver lines can be crossed to a UAS-
reporter/effector line in order to label/effect only those cells expressing Gal4. For 
example, crossing an Act5C-Gal4 driver line (BDSC stock no. 3954) to a UAS-EGFP 
reporter line (BDSC stock no. 5428) would label all cells that express Actin with EGFP. 
Changing the driver line in the previous example to nSyb-Gal4 (BDSC stock no. 51635) 
would instead label all neurons (i.e. cells that express the gene nSyb) with EGFP. 
Fig. 1.5: The life cycle of Drosophila melanogaster
Arrows with time indicate approximate time for transition from one state to the next, 
assuming flies are reared at 25C. This rapid developmental time can be 
shortened/extended by increasing/decreasing the rearing temperature. Total 
developmental time: 9 days, 11 days, 13 days, 21 days at 29C, 25C, 22C, and 18C, 
respectively. Physical size not to scale.
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In this work, I aimed to perform scRNA-seq on the cells derived from the Drosophila 
type II NB progenies at the late third-instar larval stage of development. Previous work 
has shown that the gene earmuff (erm) is required for the generation of type II INPs 
(Janssens et al., 2014; Koe et al., 2014; Li et al., 2017; Weng et al., 2010), and a 
fragment of the erm promoter known as the (R)9D11 enhancer can be used to label 
INPs and their progeny when used to drive expression of Gal4 protein (Bayraktar et al., 
2010). Using the R9D11-Gal4 driver line (BDSC stock no. 40731) therefore makes it 
possible to label the nearly 2000 type II derived cells at the late third instar larval stage 
with a fluorescent reporter, which further enables sorting these cells apart from the far 
more numerous type I derived cells in larval CNS at this stage (Brunet Avalos et al., 
2019; Cocanougher et al., 2019) using fluorescent activated cell sorting (FACS) (Bonner
et al., 1972; Herzenberg et al., 2002). 
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Chapter 2
Characterizing the Developmental Landscape of the Type-II Neuroblast Lineages
of Drosophila melanogaster
Overview1
In the type-II NB lineages of Drosophila, we set out to broadly classify the molecular 
factors that define the neural progenies of dividing INPs along three key fate-patterning 
axes, i.e., differentiation state, division number, and progenitor lineage (Fig. 2.5A) using 
targeted scRNA-seq. We created a long-living fluorescent reporter to brightly label the 
type-II progenies at the 3rd instar larval stage and FACS sorted them in preparation for 
10X Chromium scRNA-seq (Fig. 2.1). We subsequently recovered transcriptomes 
containing 11622 genes from 6092 cells. Through an iterative process of cell clustering, 
marker gene analysis, pseudotime analysis, and in situ validation, we identified genes 
that vary in expression along all three neural fate-patterning axes mentioned above. 
These genes include markers that globally define the INP, GMC, and neuron 
differentiation stages in most NB lineages. Further in silico analysis suggested 
molecular factors that are uniquely expressed in subpopulations of INPs, GMCs, 
immature and mature neurons. Subsequent in situ mRNA staining recovered the spatial 
relationship of these molecular factors, which clarified the cell division number and NB 
lineage specificity. We finally identified novel markers that exclusively label distinct 
neural subsets. These new markers further enabled building novel neural 
developmental trajectories that lead to unique neuronal cell fates. Our multi-informatic 
1This chapter largely encompasses our 2021 publication in Cell Report on this topic. Please cite:
Michki, N.S., Li, Y., Sanjasaz, K., Zhao, Y., Shen, F.Y., Walker, L.A., Cao, W., Lee, C.-Y., and Cai, D. 
(2021). The molecular landscape of neural differentiation in the developing Drosophila brain revealed by 
targeted scRNA-seq and multi-informatic analysis. Cell Rep. 35, 109039. 
17
approach to targeted scRNA-seq experimental design and analysis provides a roadmap
for navigating the differentiation process of complex brains. Our annotated scRNA-seq 
data and interactive analysis tools provide valuable resources for future discoveries.
Dissociation and FACS selection of type-II derived cells
Fig. 2.1: Experimental overview
Late third instar larvae were collected, their brains dissected and dissociated, and the 
type II cells from them sorted on a FACS machine. These cells were loaded onto a 10X 
Chromium mRNA capture chip and used to generate a sequencing library for 
downstream analysis.
[;;R9D11-Gal4/UAS-hH2B::2xmNG] larvae (n=20) were rinsed and their brains 
dissected using dissection scissors and forceps at the late L3 stage (wandering larvae) 
in ice cold Rinaldini’s solution. These brains were subsequently transferred to a poly-L-
lysine coated coverslip that was immersed in Rinaldini’s solution, attaching only the 
VNC to coverslip and leaving the central brain lobes unattached. These brain lobes 
were then further dissected using a tungsten needle by inserting the needle into each 
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brain lobe at approximately the midpoint of the lobe and moving the needle laterally. 
This process removed a lot but not all the cells on the lateral portions of each brain lobe,
which includes the developing optic lobe. The remaining OL cells were later excluded 
from our final scRNA-seq dataset using known marker genes (detailed above).
Dissected brains were transferred to a DNA low-binding 1.5mL tube in 30µL of 
dissection liquid (Rinaldini’s solution) using a p200 pipette equipped with a siliconized 
p200 tip that was cut and flame-smoothed approximately 1/4 of the way up the tip. The 
siliconized tips are lower-binding and make it less likely for brains to stick to them. 
Cutting the tip and smoothing the opening makes it easier for the brains to move into 
the tip. The 1.5mL tube was pre-filled with 50µL of fresh, cold Rinaldini’s solution, and 
upon transfer of the brains, 10µL of 20mg/mL papain, 10µL of 20mg/mL type-I 
collagenase, and 1µL of 15µM ZnCl were added to the tube, bringing the total reaction 
volume to 100µL. The tube was closed and mixed gently by flicking, then incubated on a
heat block at 37°C for 1hr. During this incubation, the tube was flicked for mixing at 
10min intervals, flicking the tube until the brains were visibly disturbed into the solution.
After the 1hr incubation, 2µL of 100µM E-64 solution was added to the mixture to stop 
the papain digestion. To break down the apparent intact brains, the mixture was 
triturated at a ~1 Hz frequency for 30 times using a p100 pipette set to 70µL and 
equipped with an uncut p200 siliconized tip. After the first 5 triturations, the brains 
should be seen largely dissociated to the naked eye. Further triturations break down the
brain completely into single-cell suspensions including the VNC, which is quite resilient 
to dissociation.
After trituration, the cell suspension was diluted with 400µL Schneider’s media + 10% 
FBS which further quenches the enzymatic digestion and stabilizes the cells. 1µL of 
DRAQ5 DNA stain (Thermo Fisher Scientific Inc.) was added to label cells apart from 
debris generated in the dissociation process.
The sorting-ready cell suspension was transferred to a 5mL plastic FACS snap-cap tube
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on ice. Cells from non-Gal4 driver brains were dissociated in a similar manner and were
sorted first on a Sony MA900 FACS machine to set the gate for using DRAQ5 to 
separate DNA containing cells from debris and set the gate for non-mNG expressing 
cells.
Sorted cells were captured in a DNA low-binding 1.5mL tube pre-filled with 100µL of 
Schneider’s media + 10% FBS. Cells were spun down at 400x g for 4 minutes and the 
solution volume was reduced to 40µL before resuspending by gentle pipetting with a 
p200 siliconized pipette tip. 5µL of this suspension was removed to count cells using an 
epifluorescence microscope by plating them in a single well of a 96 well plate, pre-filled 
with 45µL of Schneider’s media + 10% FBS. The rest of the cells were transported on 
ice to the University of Michigan Advanced Genomics Core and approximately 10,000 
cells were loaded for 10X Chromium V3 sequencing following the manufacturer’s 
instruction.
scRNA-sequencing
Two replicate experiments were performed: one on a 10X Chromium v2 chip, and one 
on a 10X Chromium v3 chip. Input cell counts were approximately equal across 
replicates. 
Approximately 10,000 type-II derived cells were used as input to a single channel of a 
10X Chromium chip. The mRNA was subsequently reverse transcribed, amplified, and 
prepared for sequencing on an Illumina NovaSeq-6000 chip (University of Michigan 
Advanced Genomics Core). The library was sequenced for a total of 385M paired-end 
reads with 28bp for the cell barcode and UMI and 110bp for cDNA inserts.
scRNA-seq mapping and downstream analysis
Reads were mapped using both Cell Ranger (for initial analysis) and STAR-solo (for our
final analysis, with mNG added to the genome) (Dobin et al., 2013) to the Drosophila 
20
genome assembly provided by ENSEMBL, build BDGP6 (2014-07).
The downstream scRNA-seq analysis was performed using scanpy (Wolf et al., 2018), 
and our analysis was formalized into the MiCV web tool generated in this work 
(https://micv.works). In brief, cells were filtered by requiring between 200-4100 unique 
genes/cell (to exclude debris and some doublets) and genes were filtered by requiring 
at least 2 cells to express it at greater than 1 UMI/cell. UMI counts were normalized to a 
total sum of 1e6 counts/cell (conversion to counts-per-million/CPM) and subsequently 
log-transformed by calculating ln(1+CPM) for each gene for each cell. The top 2000 
highly variable genes were identified using the cell-ranger method (Zheng et al., 2017) 
and these genes were used to perform a principal component analysis (PCA, n=50pcs). 
As two replicate experiments (batches) needed to be integrated across different 
sequencing chemistries (10X v2 and v3), the harmony (Korsunsky et al., 2019) data 
integration algorithm was used to batch-correct this PCA representation of the data 
before proceeding to neighborhood identification (k=20), and finally a UMAP projection 
(2D). Clusters were identified using the Leiden algorithm (Traag et al., 2019), an 
optimized version of the Louvain algorithm (Blondel et al., 2008), with varying clustering 
resolutions. For most of the type-II only UMAP projections displayed in this work, the 
clustering resolution was 0.6, with 1 being a standard default (and higher numbers 
leading to more granular clustering of cells). Marker genes were identified using logistic 
regression analysis, implemented in scanpy.
Type-II neuroblast derived cells are uniquely identified from the mixed optic lobe 
cell population using descriptive quality control metrics and clustering
To perform targeted scRNA-seq, we brightly labeled the type-II NB progenies with a 
long-lasting fluorescent reporter. We created an UAS-hH2B::2xmNG reporter fly, in 
which two copies of the mNeonGreen (2xmNG) fluorescent protein are fused to the C’-
terminus of the human histone 2B protein (hH2B). This leverages the expression of 
multiple copies of a bright fluorescent protein alongside the slower turn-over rate of the 
histone protein (Tumbar et al., 2004). To validate labeling fidelity, we crossed UAS-
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hH2B::2xmNG to an R9D11-Gal4 driver (Weng et al., 2010). We found that mNG 
labeled type-II NB progenies and a small subset of medial optic lobe (OL) cells in larval 
brains (Fig. 2.2A). When comparing our UAS-hH2B::2xmNG to the previously used 
UAS-IVS-myr::tdTomato reporter, we found that the membrane-targeted myr::tdTomato 
cells formed clusters that are smaller than the hH2B::2xmNG labeled cells (Fig. 2.2B-D).
This indicates that the slow hH2B::2xmNG turnover preserved labeling in progeny cells 
in which Gal4 was no longer expressed. Finally, the bright nuclear mNG labeling 
enabled reliable FACS selection for targeted 10x Chromium scRNA-seq (Fig. 2.1).
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Figure 2.2: A long-lasting nucleus UAS-hH2B::2xFP (mNeonGreen/tagBFP) 
reporter labels more cells in the type-II progenies than the membrane UAS-IVS-
myc::tdTomato reporter
(A) A max-Z projection of the novel UAS-hH2B::2xmNeonGreen reporter driven under 
the control of R9D11-Gal4 at the third instar larval developmental stage. The type-II 
progenies are outlined in green dashed lines, and the approximate boundary between 
the central brain and the developing optic lobe (OL) is marked by the yellow dashed 
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line. Gamma correction (γ = 0.5) was applied to better visualize the dimmer OL cells. (B)
The membrane-bound tdTomato reporter is driven under the control of R9D11-Gal4 and
its lineage labeling is compared to that of our (C) nucleus-targeted 2xmNG reporter. (D) 
Quantifications of labeled cells in clusters DM1 and DM2 in late third instar larvae 
brains. Bars represent the mean of manual cell counts from DM1 and DM2 in three 
brains for each genotype; points represent cell counts for the individual replicates. Scale
bars, 30 μm in overviews of (A,B,C), 10 μm in insets of (B,C).
Subsequently, we projected the scRNA-seq data onto a 2D UMAP plot and overlaid the 
counts of all genes, unique transcripts (UMI), and mitochondrial genes as part of routine
scRNA-seq quality control (Fig. 2.3).
Fig. 2.3: Sequencing QC metrics indicate that captured cells are healthy and 
diverse in transcriptional activity
(A) UMAP with colorimetric and numerical labels for each automatically assigned cluster
(Leiden algorithm, resolution=0.5). (B-D) UMAP of cells overlaid with their ln(1+UMI 
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counts), number of unique genes detected, and percentage of mitochondrial genes, 
respectively. (E-G) The QC metrics from above but summarized as boxplots on a per-
cluster basis. Clusters 3, 4, and 6 are large groups of cells that have particularly high 
UMI counts and gene detection rates, indicating that they are transcriptionally very 
active. Cluster 1 is the group of type-II derived INPs described in this work. Cluster 6 
cells are likely glia based on the expression of repo (Fig. 2.6) and cluster 8 cells are 
likely progenitors in the OL cells based on the expression of CycE (Fig. 2.4). Cluster 4 is
a group of maturing neurons that has a higher than average gene detection rate, and 
strongly expresses Imp (data not shown), an IGF-II RNA-binding protein that is 
responsible for a number of RNA trafficking functions, notably being required for axonal 
growth and remodeling (Medioni et al. 2014). As the type-II neuronal progenies extend 
large axonal bundles across the commissure during development, it is possible that this 
transcriptionally active group of Imp+ neurons are the ones actively undergoing this 
process. Boxes represent interquartile range (IQR) of data; midline represents median; 
whiskers represent range, with the exception of outliers which are represented by points
(values are 1.5 times the IQR beyond the low or high quartile). (H) Predicted 
sequencing saturation curve generated using CellRanger, indicating that at our 
sequencing depth we have recovered nearly 80% of unique genes that might be found 
in each cell.
When overlaying the hH2B::2xmNG reporter transcript counts, we found that mNG 
transcripts were expressed non-uniformly, with pockets of cells expressing the 
hH2B::2xmNG transcript at a significantly higher level than others in the dataset (Fig. 
2.4A). To examine whether this non-uniform expression pattern reflects true biological 
variance, we performed in situ RNA staining for mNG using the HCRv3 protocol (Choi et
al., 2018) and imaged the native mNG fluorescence to compare the relationship of mNG
transcripts and proteins (Methods). We found that each of the type-II clusters indeed 
expresses a high level of mNG transcripts in only a small subpopulation of cells near the
tip of each lineage (Fig. 2.4B-D). This spatial localization, coupled with co-expression of 
mNG transcripts with D in CycE+ cells (data not shown) leads us to conclude that the 
R9D11 enhancer fragment’s expression is tightly restricted to newly-born INPs and their
daughter GMCs, emphasizing the need for long-living reporters for investigation of 
neural subtypes derived from the type-II NBs.
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Fig. 2.4: R9D11-Gal4 driven reporter mRNA expression is restricted to a small 
portion of each type-II lineage
(A) A composite maximum z-projection of a late third instar larval brain expressing our 
novel UAS-hH2B::2xmNeonGreen (mNG) reporter under the control of R9D11-Gal4, 
with native mNG fluorescence labeling the type-II progenies and mNG mRNA labeled 
using our mNG HCR v3 probes. At the tip of each type-II lineage, there is a burst of 
expression of mNG transcripts (middle panel) that does not persist throughout the 
lineage but rather remains restricted to what is presumably the youngest mINPs. (B) 
This assessment is further validated using our scRNA-seq data, wherein we find that 
mapped mNG transcript expression is multiple log2-fold higher in young mINPs and 
their daughter GMCs, based on the expression of CycE/mira for mINPs and Sp1 for 
young mINPs and their progeny (C-E) (see also Fig. 2.9 in the main text). In the optic 
lobe (the large connected group of cells on the right-hand side of the UMAP projection), 
the expression is not restricted to cells with the highest CycE/mira expression and so it 
is possible that the R9D11 enhancer element is active in a non-progenitor population in 
the optic lobe. Scale bars: 30 μm.
To further ensure the specificity of our analysis to type-II cells, we performed an in silico
filtering to exclude the optic-lobe cells that are also labeled by R9D11-Gal4 (Bayraktar 
et al., 2010). Based on prior literature, at least two genes are not expressed in the 
developing optic-lobe (lncRNA:cherub and dati; see in situ expression patterns from 
(Landskron et al., 2018; Schinaman et al., 2014), respectively). In the unsupervised 
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clustering and UMAP projection, two groups of cells can be clearly separated as 
cherub+/dati+ and cherub-/dati-, which we define as putative type-II and OL cells, 
respectively (Fig. 2.5C-E). 
Fig. 2.5: Drosophila type-II neuronal fate specification model, experiment 
overview, and in silico dissection of the optic lobe and type-II derived cells
(A) A diagram of the major axes that determine cell “state” in this work. Each sequenced
cell is defined in part by factors that are specific to the lineage identity, intermediate 
progenitor cell division number, and differentiation state. (B) Overview of our targeted 
scRNA-seq experimental strategy. (C) Cells plotted in the first 2 dimensions of a UMAP 
projection. Color represents automatic cluster assignment by the Leiden algorithm 
(resolution = 0.5). (D-E) Expression of the long non-coding RNA cherub and the 
transcription factor dati are known to be exclusive of the optic lobe in 3rd instar larvae. 
Groups of cells that lack expression of these genes are likely optic lobe cells that also 
express Gal4 under the control of the R9D11 fragment of the erm promoter. (F) 
Separating the putative type-II/optic lobe cells into two groups and performing logistic 
regression analysis reveals genes that are up-regulated between the two. (G) A single 
z-slice of one brain lobe from the developing (mid L3 stage) larval brain. UAS-
hH2B::2xtagBFP is driven under the control of R9D11-Gal4 and marks the type-II 
lineages, only four of which are visible in this z-slice. lncRNA:cherub and dati mRNA are
largely expressed by type-II cells, while bi and mamo mRNA are largely expressed in 
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the developing optic lobe (boundary marked by the diagonal line). Scale bars: 10um in 
all images.
To identify other potential marker genes to separate OL and type-II cells, we performed 
a logistic regression-based marker gene analysis (Ntranos et al., 2018) comparing 
these two major groups against one another (Fig. 2.5F). The transcription factors mamo
and bi are upregulated in the putative OL cells when compared to the putative type-II 
cells, among others. To confirm this, we generated HCR probes against mamo and bi 
as novel markers for the OL, and lncRNA:cherub and dati as markers for cells not in the
OL. We subsequently stained larval R9D11-hH2B::2xtagBFP brains (Fig. 2.5G), and 
clearly show that bi and mamo are both predominantly expressed in the OL, and 
lncRNA:cherub and dati are predominantly excluded from the OL. Why mamo is 
upregulated in cells in the OL is unknown. Prior work has shown that mamo is required 
for specification of ’/ꞵ’ mushroom body neurons in the developing CNS ⍺ (Liu et al., 
2019). Further study of its role in the OL may elucidate novel function there. On the 
other hand, bi has been shown to be indispensable for neural differentiation in the OL 
(Pflugfelder et al., 1990). Our finding of bi being excluded from the type-II lineages 
expands our knowledge of its expression specificity.
From our in silico filtering process, we confidently separated the type-II derived cells 
from optic lobe cells that were also captured in our scRNA-seq experiment. Only these 
type-II derived cells were carried forward for our downstream analysis.
Pseudotime analysis describes the continuous differentiation stages of type-II 
derived cells
Knowing that the R9D11-hH2B::2xmNG reporter specifically labels type-II progenies 
from INPs to maturing neurons, we aimed to first align each cell along a continuous 
cellular differentiation state axis (Fig. 2.5A). We expected this would reveal the most 
prominent underlying structure of our data because, in the case of type-II neurogenesis,
all cells will similarly transition through the INP, to GMC, to immature, to mature neuron 
differentiation states. Using the Markov chain-based pseudotime analysis algorithm 
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Palantir was a natural choice as Markov chains describe discrete transitions that occur 
randomly based upon a continuous probability distribution (Setty et al., 2019). Given a 
properly chosen starting cell, Palantir aligns cells in our scRNA-seq data based upon 
the path of fewest transcriptomic changes propagating from the starting cell.
Cells expressing high levels of the INP markers CycE and D are good candidate starting
cells for Palantir (Bayraktar and Doe, 2013; Yang et al., 2017). To easily identify these 
cells from the UMAP plot, we built a Multi-informatic Cellular Visualization web tool 
(MiCV) to display the single cell co-expression pattern of multiple genes in the 2D/3D 
UMAP plots. Furthermore, users can conveniently select a subset of cells for specific 
analysis, such as picking the starting cell(s) for Palantir, by combining mouse-click 
selections from the parallel plots generated by MiCV (Methods). We overlaid the 
pseudotime result onto the reprojected 2D UMAP plot that only included type-II NB 
derived cells. Based on the expression of known marker genes (Fig. 2.6), we predicted 
INP, GMC, immature, and mature neuron clusters (Fig. 2.7A, dash lines). Interestingly, 
these cell maturation state clusters aligned well with the pseudotime arrangement. For 
example, using MiCV, we displayed the single cell co-expression pattern of CycE, dap, 
and nSyb (Fig. 2.7B), which are known to distinguish the INP, GMC/immature neuron, 
and mature neuron states, respectively, and found their UMAP positions matched well 
with their pseudotime alignments (Fig. 2.7A).






















Fig. 2.6: Marker gene-based differentiation state scoring enables robust 
identification of cell differentiation state without manual annotation
(A) All cells were scored using the score_genes function from scanpy with the following 
marker genes defining each differentiation state (see table below). These scores were 
normalized to be within the range of [0,1], with 1 indicating that all of the marker genes 
for that cell type were expressed at high levels in that particular cell. (B)  Type-II NB 
derived cells were scored as described in (A). (C) Marker gene analysis revealed genes
that specify clusters of cells in distinct maturation/differentiation states. Many GMC 
marker genes are also highly expressed in INPs/progenitors. Although pseudotime 
analysis provides a more holistic view of a gene’s dynamic change along the cell 
differentiation trajectory (Fig. 2.7), this small set of genes are robust identifiers for 
determining cell differentiation states. INP, intermediate progenitor cell; GMC, ganglion 
mother cell; iN, immature neuron; mN, matured/maturing neuron.
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Fig. 2.7: Pseudotime analysis reveals signature genes that vary along the cell 
differentiation axis
(A) Pseudotime analysis establishes a global ordering of cells along the differentiation 
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state axis. (B) A multi-color UMAP expression plot generated by the MiCV web tool 
shows the expression of 3 canonical marker genes for the INP, GMC, and mature 
neuron states. (C) The pseudo-temporal expression pattern of 4 genes that are known 
markers for the 4 major differentiation states. (D-G) Pseudo-temporal expression 
patterns of groups of marker genes that do not have known functions associated with 
cellular differentiation state. These gene expression trends are similar to the known 
marker genes plotted in (C). (H, I) HCRv3 in situ mRNA staining images for both known 
(H) and novel (I) differentiation state marker genes in single z-slices of the DL2 lineage 
of mid 3rd instar larval brains. UAS-hH2B::2xtagBFP is driven under the control of 
R9D11-Gal4 and marks the type-II lineages. Asterisks denote the location of the 
putative type-II NB. Thick dashed lines denote the boundaries of the tagBFP labeled 
type-II NB progenies. Thin dotted lines denote the boundaries of type-II progeny cells 
expressing indicated mRNAs. (J-M) Multi-color UMAP expression plots illustrate the 
expression pattern of the canonical and novel marker genes from (H) and (I), 
respectively. Scale bars: 30 μm in overviews of (H, I), 10μm in insets of (H, I).
To describe the dynamics of gene expression across pseudotime, and thus the 
differentiation process, we fit a gene expression trend line to each gene detected in our 
scRNA-seq dataset using PyGAM (Servén et al., 2018). Indeed, we found that the 
expression peaks of four marker genes, i.e. CycE for INPs (Yang et al., 2017), dap for 
GMCs (Lane et al., 1996; de Nooij et al., 1996), Hey for a subset of the transient 
immature neuronal state (Monastirioti et al., 2010), and nSyb for maturing neurons 
(Deitcher et al., 1998), aligned in this exact differentiation order along the calculated 
pseudotimeline (Fig. 2.7C). Hence, we can use the relative expression levels of these 
genes to approximate the boundaries of the continuously changing differentiation states 
(Fig. 2.7A, dashed lines) in pseudotime. Subsequently, we performed gene expression 
trend clustering using phenograph (Levine et al., 2015) to screen novel putative marker 
genes whose expression trend matched one of the four known marker genes’ (Fig. 
2.7D-G). Independently, we used a marker gene-based differentiation state scoring 
(Wolf et al., 2018) strategy to separate these differentiation stages and found similar 
sets of marker genes (Fig. 2.6). Interestingly, many of the putative marker genes do not 
have any known function related to neural differentiation. Further pathway analysis and 
gene manipulation studies will be needed to explore their exact roles in type-II 
neurogenesis.
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Nonetheless, we profiled the in situ expression patterns of some putative marker genes 
we identified in this analysis. We first synthesized HCRv3 probes against the canonical 
makers CycE, dap, Hey, and nSyb transcripts (Methods) and used these probes to 
investigate their expression pattern in the type-II NB derived cells using our novel 
reporter fly. As predicted, these genes form largely non-overlapping expression patterns
in the larval brain (Fig. 2.7H, left panel). We found that CycE transcripts were expressed
in large neuroblasts as indicated by the large cell bodies (Fig. 2.7H, right panels, 
asterisk) and in smaller tagBFP positive cells as a marker for replicating INPs. As 
predicted, dap, Hey, and nSyb transcripts expressed in bands of cells that were 
sequentially positioned away from the neuroblast (Fig. 2.7H, right panels, dashed lines).
Next, from the gene expression trend clustering result (Fig. 2.7D-G), we selected four 
candidate markers and performed similar HCR in situ mRNA profiling. The in situ results
suggest that ytr, tap, E(spl)m6-BFM, and jim transcripts express in unique patterns (Fig.
2.7I, right panels) and the co-expression MiCV plots indicate that these markers largely 
overlap the canonical makers in the respective cells (Fig. 2.7J-M). In particular, 
E(spl)m6-BFM, and jim were expressed almost exclusively in immature neurons and 
maturing neurons, respectively (Fig. 2.7L-M). However, while the putative INP marker 
ytr expressed in 96% of all the INPs, it also expressed in 37% of GMCs and 38% of 
maturing neurons (Fig. 2.7J). This observation indicates that ytr broadly expresses in 
INPs and that its expression may be selectively maintained in a subset of GMCs and 
their progeny neurons. The putative GMC marker tap appears to express in subsets of 
INPs and approximately half of the immature neurons (Fig. 2.7K). This suggests that tap
may be a gene that defines one daughter neuron during their mother GMC’s terminal 
cell division.
Though many genes that trend along the differentiation state axis are potentially 
interesting, we highlight here the gene E(spl)m6-BFM, a member of the Notch-
responsive subgroup of the “enhancer of split” family of transcription factors (Lai et al., 
2000). This family of proteins is responsible for regulating a variety of developmental 
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processes (Maier et al., 1993) and their group’s function in balancing the self-renewal of
differentiation in the type-II neuroblasts of Drosophila has recently been described (Li et 
al., 2017). However, the specific function or restricted spatial expression of E(spl)m6-
BFM in the developing larval brain has not been established. Based on our analysis, 
E(spl)m6-BFM marks a subset of the cells in the transient immature neuronal state 
which comes about directly after the mother GMC’s terminal cell division. This is similar 
to Hey, a previously identified immature neuron marker, which is upregulated in only 
one of the two daughter neurons of this terminal GMC division (Monastirioti et al., 2010) 
and activates in a Notch-dependent manner. Our scRNA-seq data indicates that 
E(spl)m6-BFM is expressed in both Hey+ cells and Hey- cells that have similar 
pseudotime values, though Hey+/E(spl)m6-BFM- cells are also present (Fig. 2.7L). To 
validate this, we used HCR probes for both Hey and E(spl)m6-BFM and identified 
subsets of immature neurons that were only Hey+, only E(spl)m6-BFM+, or Hey and 
E(spl)m6-BFM double-positive (Fig. 2.8). Similar to E(spl)m6-BFM, Rbp, a protein 
known to be functionally required for synaptic homeostasis and neurotransmitter release
(Liu et al., 2011; Müller et al., 2015), is also upregulated only in this immature neuronal 
subset (data not shown). Further study will be desired to understand why either of these
genes undergo a burst of expression in the immature neuronal state, and to establish 
their functional roles at the protein level.
Fig. 2.8: The genes Hey and E(spl)m6-BFM mark an immature neural state
(A) Single z-slice of mid L3 larval brain; type-II lineages are marked with R9D11::hH2B-
2xtagBFP. In lineages DM2 (top) and DM5/6 (bottom), Hey and E(spl)m6-BFM are 
clearly shown to be closely expressed in a small and restricted cell population that are 
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not nSyb+ maturing neurons. As previous studies revealed that Hey is strictly expressed
in immature neurons, it is highly plausible to hypothesize that E(spl)m6-BFM is also 
expressed strictly in the same state, yet with a differential pattern compared to that of 
Hey. Scale bars: 30 μm in overview, 10μm in insets.
INP and GMC sub-clustering enables the identification of novel maturation 
pathways that are convolved with the  canonical Dichaete, grainy-head, eyeless 
transitions
Having used pseudotime analysis to define the major differentiation states in the type-II 
neurogenesis process, we next characterized the cellular heterogeneity within these 
states using automated scRNA-seq clustering analysis. Such analysis may or may not 
obviously reflect previously established models of cell type differentiation/diversity, 
especially when this diversity could refer to any of/all the axes of cell type differentiation 
(Fig. 2.5A). Nonetheless, we performed Leiden clustering (Traag et al., 2019) with a low
resolution (0.6) and overlaid the result on the reprojected UMAP (Fig. 2.9A, left). We 
found that cluster 1 and 0 included 561 and 563 cells, which correspond to the INP and 
GMC populations in the above-mentioned pseudotime analysis, respectively. 
Subsequently, we took these putative INP and GMC cells and found they could be 
clustered into four groups of INPs and four groups of GMCs (Fig. 2.9A, right). 
To discover which genes distinguished each subcluster, we performed logistic 
regression-based marker gene analysis and plotted the top 10 genes that defined the 
INP (Fig. 2.9B) or GMC subclusters (Fig. 2.9C). We found that this clustering result 
reflects a convolution of the lineage-specific canonical Dichaete, grainy-head, eyeless 
transitions outlined in (Bayraktar and Doe, 2013), which have been indicated to 
sequentially express in young to old INPs over the course of their division cycles 
(Bayraktar and Doe, 2013). D expression was rather specific in 74% of subcluster 4 INP
cells and in 78% of subcluster 1 GMC cells, while only expressing in fewer than 28% of 
other subcluster cells (Fig. 2.9D). On the contrary, grh and ey expressions are 
intermingled in the other subclusters (Fig. 2.9E and F, respectively). 
35
Fig. 2.9: Sub-clustering of INPs and GMCs reveals transcription factors beyond 
the canonical D-grh-ey transition that vary along a combination of the NB lineage 
and INP division number patterning axes
(A) Left panel, leiden clustering reveals INPs and GMCs to be in cluster 1 and 0, 
respectively. Right panel, higher resolution clustering on separated INPs and GMCs 
further divides them into 4 subclusters each. (B, C) Marker gene analysis revealed that 
mostly transcription factors specific INP and GMC subclusters, respectively. (D-F) 
Expression UMAP plots of the well-established temporally-varying INP genes D, grh, 
and ey, respectively. D appears to separate cleanly at the mRNA level in the INPs of 
our dataset, however, grh and ey are broadly co-expressed. (G-I) Expression UMAP 
plots of the INP/GMC cluster-specific genes Sp1, TfAP-2, and Fas3, which are found to 
correlate INP subclusters 3, 4, and 5 to GMC subclusters 0, 1, and 6, respectively. (J) A
correlation plot shows the number of top 100 marker genes that are shared between 
each INP and GMC subcluster. This simple similarity metric indicates a hypothesis that 
cells in GMC subclusters 0, 1, and 6 are the direct progenies of cells in INP subcluster 
3, 4, and 5, respectively. INP group 2 and GMC group 7 are both clearly distinct from 
the other INP and GMC subtypes, but share very few marker genes and so are unlikely 
to be related.
Interestingly, we found that Sp1, TfAP-2, and Fas3, among the top marker genes in this 
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clustering analysis, not only expressed in segregated subclusters, but also marked both 
INP and GMC subclusters (Fig. 2.9G, 3H, and 3I, respectively). We suspected that the 
GMC subclusters specified by these genes might be the direct progenies of the INP 
subclusters that carry over the Sp1, TfAP-2, and Fas3 transcripts. We subsequently 
counted the number of top 100 marker genes that were shared between each of the INP
and GMC subclusters. The correlation plot strongly suggests that GMC subclusters 0, 1,
and 6 are likely the progeny of INP subclusters 3, 4, and 5, respectively (Fig. 2.9J).
The choice of clustering resolution can be somewhat arbitrary, and the 8 subclusters for
INPs and for GMCs here may represent a surface level of INP patterning that can be 
further broken down into more subtypes. Since we saw a clear link between 6 of these 8
subclusters, we decided to pursue in situ validation experiments for the marker genes 
identified at the 8-subcluster resolution in follow up experiments, and aimed to do so in 
an exploratory manner, taking Sp1, TfAP-2, and Fas3 (the top marker genes for the 
relevant GMC subclusters) as promising marker genes to investigate further.
The transcription factor  Sp1 is expressed in young INPs throughout the DM1-6
and DL1 lineages and marks a unique neural progeny
We first aimed to in situ profile the transcript expression of Sp1, a Cys2His2-type zinc 
finger transcription factor that is necessary for the specification of type-II neuroblasts 
(Álvarez and Díaz-Benjumea, 2018). We reasoned that this, along with the apparent 
coexpression of Sp1 with D in the INPs of our scRNA-seq dataset (Fig. 2.9D, G, 
respectively), would imply that Sp1 may be broadly expressed in young, newly-matured 
INPs of most type-II NB lineages. We synthesized HCRv3 probes against Sp1 and D 
transcripts (Methods) and validated their specificity using gene-trap reporter flies (Fig. 
2.10). 
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Fig. 2.10: Sp1::GFP fusion protein and Sp1 mRNA co-localize in situ and label 
both dpn+ INPs and axon-producing neurons
(A) Single z-slice of a mid 3rd instar Sp1::GFP transgenic larval brain, showing native 
fluorescence of GFP in cyan (right), HCR stained Sp1 mRNA in magenta (middle), and 
a composite of the two (left). Sp1 mRNA signal is made up of puncta scattered around 
the labeled cells. Sp1 protein, being a transcription factor, leads to GFP expression 
being largely localized to the nucleus. (B) Single z-slice of a mid 3rd instar ;R9D11-
CD4::tdTomato;Sp1::GFP larval brain stained with an antibody specific to dpn. The co-
localization of dpn, Sp1, and membrane-bound tdTomato proteins indicates that Sp1 is 
translated in both neurons and INPs of the type-II lineage, as evidenced by the labelling 
of cells that either produce membrane-tdTomato-labeled axons or are dpn+, 
respectively. Scale bars: 30 μm in the overview of (A); 10 μm in insets of (A) and (B).
When assessing their expression patterns in the type-II NB derived cells, we found that 
Sp1 mRNA was expressed prominently in all type-II lineages with the possible 
exception of DL2 (Fig. 2.11A, B). On the contrary, D mRNA expressed prominently in 
DM1-3, and in much smaller subsets of cells in lineages DM4-6 (data not shown), which
is consistent with previous observations (Bayraktar and Doe, 2013). 
Our scRNA-seq data indicates that while Sp1 co-expressed with D in more than 30% of 
INPs (Fig. 2.11C), 8% and 16% of all INPs are Sp1+/D- and Sp1-/D+, respectively. To 
validate the presence of these INP populations in situ, we used our HCR protocol to co-
stain Sp1 and D mRNA (Fig. 2.11D). We show that, for instance in the DM6 lineage, an 
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Sp1+, D+ INP progeny can be identified directly adjacent to cells where either Sp1 or D 
is exclusively expressed (Fig. 2.11D, enlarged box). Furthermore, we overlaid Sp1 or D 
expressions on the UMAP plot, and found that these two transcripts continue to express
in maturing neurons of two exclusive subsets (detailed below). This is consistent with a 
previous study, which found that the D expressing young INPs specifically give rise to D
expressing neurons (Bayraktar and Doe, 2013). Therefore, we hypothesize that 
Sp1+/D+ INPs may transition to Sp1 or D exclusively expressing INPs, which give rise 
to distinct neural subtypes. To specify whether Sp1 protein is expressed in neurons, we 
labeled the type-II progenies with a membrane-bound tdTomato (R9D11-
CD4::tdTomato) to visualize neuron’s characteristic axonal projections and coupled with
an Sp1::GFP reporter line. We show as an example that the DM3 lineage generates 
many neurons that form a tdTomato+ neurite bundle that are also GFP+, which 
indicates the generation of Sp1+ neural progeny (Fig. 2.10B).
Next, we wondered whether Sp1 is like D that expresses strictly in young INPs. We 
quantified our scRNA-seq data and found that Sp1 coexpressed with the two canonical 
late INP markers grh and ey only in a small subset of INPs (Fig. 2.11C). Taken together,
these data support the hypothesis that Sp1, much like D, is expressed broadly in INPs 
with low division numbers and that these INPs are responsible for producing a neural 
progeny similarly marked by Sp1 expression that is distinct from the D+ neural progeny.
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Fig. 2.11: Sp1, TfAP-2, and Fas3 are each expressed by INPs of specific NB 
lineages
(A, B) Maximum Z-projections (45μm thick) show tagBFP fluorescence and Sp1 mRNA 
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HCR staining in an L3 larval ;;R9D11-Gal4/UAS-H2B::tagBFP fly brain, respectively. 
Green dashed lines indicate the expression of Sp1 mRNA in all type-II NB derived 
lineages except for DL2. (C) Co-expression quantification of Sp1 with D, grh, and ey in 
all INPs (n=561). (D) HCR staining showcases the expression patterns of Sp1 and D 
mRNAs in lineage DM6. Dashed lines highlight region 1 of INPs that co-express Sp1 
and D mRNA, region 2 of non-INP cells where Sp1 mRNA alone is detected, and region
3 of non-INP cells where D mRNA alone is detected. White dotted lines denote the DM6
lineage boundary. Asterisks denote the position of the DM6 neuroblast. (E, F) Maximum
Z-projections (45μm thick) as in (B,C), with TfAP-2 mRNA HCR staining. Within the 
type-II NB lineages, TfAP-2 mRNA is highly expressed in cells belonging to DM 4-6 
(dashed lines) and possibly DL1. Though some expression is seen nearby to DM1-3, 
TfAP-2 is not expressed in tagBFP+ cells belonging to those lineages (arrowheads). (G)
Co-expression quantification of TfAP-2 as in (C). (H) HCR staining showcases the 
expression patterns of CycE, Sp1 and TfAP-2 mRNAs in lineage DM6, where we can 
find TfAP-2 expressed in CycE+ INPs that have Sp1 expression (green dashed lines) or
not (red dashed lines), as well as in CycE- progeny cells (blue dashed lines). (I, J) 
Maximum Z-projections (45μm thick) as in (B,C), with Fas3 mRNA HCR staining. Within
the type-II NB lineages, Fas3 mRNA is highly expressed in cells belonging to DM 1-3 
(dashed lines). (K) Co-expression quantification of Fas3 as in (C). (L) HCR staining 
showcases the expression patterns of CycE, Fas3, and Sp1 mRNAs in lineage DM2. 
We find a clear expression of Fas3 in both INPs and their progeny in NB lineage DM2, 
where we can find Fas3 expressed in CycE+ INPs that have Sp1 expression (green 
dashed lines) or not (red dashed lines), as well as in CycE- progeny cells (blue dashed 
lines). Scale bars: 30 μm in (A, B, E, F, I, J) and in overviews of (D, H, L); 10 μm in 
insets of (D, H, L). Minimum expression threshold: ln(CPM+1)>4.5 in (C, G, K).
The transcription factor TfAP-2 and cell adhesion molecule Fas3 are each 
expressed in INPs of specific type-II neuroblast lineages
We next characterized the spatial expression patterns of TfAP-2 and Fas3, selected 
markers for the other two major putative INP subtypes identified in our low-resolution 
clustering (Fig. 2.9). We generated HCR probes against mRNA of TfAP-2 and Fas3 in a
similar manner to Sp1 and probed their expression in reporter flies in order to identify 
which type-II NBs generate their respective INP subsets. Unlike Sp1, however, TfAP-2 
and Fas3 transcripts are expressed much more broadly across the brain and are not 
restricted to the type-II lineages (Fig. 2.11F, J). 
41
Within the type-II progenies, TfAP-2 mRNA appeared to be expressed prominently in 
INPs of the DM4-6 lineages as well as a subset of their downstream progeny (Fig. 
2.11E, F, green outline). However, we did not observe strong TfAP-2 expression in any 
other lineage, implying that expression of this marker is primarily lineage restricted (Fig. 
2.11E, F, arrowheads). Interestingly, TfAP-2 co-expressed in fewer D+ but many more 
grh/ey+ INPs than Sp1 does in our scRNAseq data, which indicates that TfAP-2+ INPs 
have likely undergone some cell divisions before expressing this marker gene (Fig. 
2.11C vs 4G). Although TfAP-2 expresses in fewer lineages than Sp1, our scRNA-seq 
data (not shown) and in situ profiling (Fig. 2.11H) showed that these two genes do 
indeed co-express in cells belonging to those few lineages. TfAP-2 plays broad roles in 
development (Monge et al., 2001), but in the context of the central brain it has been 
shown to play a role in developing and maintaining the neural circuitry required for 
night-sleep in adult flies (Kucherenko et al., 2016). Consistently, we found in our 
scRNAseq data that TfAP-2 expressed in a subset of neurons that are distinct from the 
Sp1+ or D+ population (data not shown). TfAP-2’s expression in neurons is distinct from
the previously identified late INP progeny genes grh and ey; the latter two were not 
found in neurons in our scRNA-seq data (data not shown). TfAP-2 (ap-2) is significantly 
orthologous to the human transcription factors TFAP2A/B (Flybase curators, 2019), and 
its role in sleep can be traced back to C. elegans (Turek et al., 2013). Taken together, 
this would imply that at least this particular role for TfAP-2 in the central brain may be 
evolutionarily conserved and that the neurons generated by TfAP-2+ INPs in the DM4-6 
lineages may play a role in night-sleep circuit maintenance.
Based on our in situ RNA staining, Fas3 mRNA was found to express most prominently 
in the INPs of DM1-3 (Fig. 2.11I, J). Similar to TfAP-2, our scRNAseq data suggests 
that Fas3 co-expressed in fewer D+ but many more grh/ey+ INPs than Sp1 does, which 
indicates that Fas3 INPs have likely undergone some cell divisions before expressing 
this marker gene (Fig. 2.11C vs K). Again, our scRNA-seq data (not shown) and in situ 
profiling (Fig. 2.11L) showed that Fas3 and Sp1 co-express in a significant fraction of 
cells. Fas3 is interesting as a marker gene for INPs as it is not a transcription factor but 
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rather a membrane-bound, homophilic cell adhesion molecule that plays a strong role in
synaptic targeting and axonal guidance in a subset of neurons in the central and 
peripheral nervous systems (Kose et al., 1997; Snow et al., 1989), along with cell 
adhesion-mediated morphological development throughout the entirety of the fly (Wells 
et al., 2013). Why Fas3 would be expressed so strongly in a subset of INPs is unknown.
A unique combination of transcription factors and surface molecules define 
putative neural sub-progenies of young INPs
With low resolution (0.6) global clustering, our scRNA-seq data already showed a much 
greater subtype diversity in neurons (12 clusters) than in GMCs or INPs (1 cluster each)
(Fig. 2.12A). We performed logistic-regression based marker gene analysis on these 
specific clusters to identify the top 100 marker genes for each cluster that are most 
uniquely expressed with the top 10 marker genes of clusters 4, 6, and 8 are plotted in 
Fig. 2.12B (full plot for all clusters are shown in Fig. 2.13). Subsequently, we analyzed 
the top 100 marker genes using the DAVID Functional Annotation Tool (Huang et al., 
2009a, 2009b) in order to identify sets of genes that form functionally associated groups
based on associated gene ontology (GO) terms. We identified the first GO term from the
top three highly enriched functional groups and find that these terms indicate that 
transcription factors and surface molecules are predominant markers for these three 
(Fig. 2.12C), as well as all other neural subsets (data not shown).
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Fig. 2.12: A unique combination of transcription factors and surface molecules 
define putative neural sub-progenies of young INPs
(A) Automatic Leiden clustering (resolution = 0.6) of the type-II scRNA-seq data, with 
putative neural subtypes 4, 6, and 8 outlined, representing the Sp1, bsh, and D+ neural 
progenies, respectively. (B) Marker gene detection for the three selected neural 
subtypes showing the top 15 marker genes as identified using the t-test_overestim_var 
function in scanpy. (C) Top gene ontology (GO) functional annotations for the top 100 
marker genes for cells in each of clusters 4, 6, and 8, respectively (p-values are 
Benjamini corrected; n_genes refers to the number of marker genes annotated with the 
respective GO term). (D, E, F) Log-fold expression values of Sp1, bsh, and D, 
respectively, showing three unique neural lineages are marked by these three 
transcription factors. (G, J) Log-fold expression values of the transcription factor Ets65A
and the cell surface molecule Fas3 that mark the Sp1+ neural progeny. (H, K) Log-fold 
expression of the transcription factor Awh and surface molecule Fas2 that mark the 
bsh+ neural progeny. (I, L) Log-fold expression of the transcription factor dac and 
surface molecule Toll-6 that mark the D+ neural progeny. (M, N) Maximum Z-projections
show tagBFP fluorescence and Fas3 antibody staining in an L3 larval 
;;R9D11-Gal4/UAS-H2B::tagBFP reporter fly brain, respectively. It appears that neurons
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from DM1-3 that produce commissure-crossing axons are prominently labeled by Fas3, 
whereas neurons from DM4-6 are largely unstained. Scale bars: 30 μm in (M, N).
In the (Bayraktar and Doe, 2013) study, bsh was found to express in a non-overlapping 
subset of neurons that do not express D in the young INP progeny. The same study 
also specified that there are other young INP derived neurons are Bsh- and D-, whose 
markers were not identified using the available method and antibody probes. 
Interestingly, our automatic analysis reveals that neuron clusters 4, 6, and 8 
differentially express Sp1+, D+, and bsh+ respectively (Fig. 2.12B). As we show that 
Sp1 expresses in young INPs, it is plausible that Sp1 is a marker gene that labels the 
previously unspecified young INP derived neurons. Indeed, our scRNAseq data shows 
that Sp1, D, and bsh were expressed in three distinct maturing neuron populations (Fig. 
2.12D, F, and E, respectively). This in silico analysis permits rapid identification of 
transcription factors that potentially belong to the same regulatory pathways to specify 
neuronal fate. For example, selected from the specific marker gene list, the transcription
factors Ets65A, dac, and Awh are highly co-expressed with neurons expression Sp1, D, 
and bsh, respectively (Fig. 2.12G, I, H, respectively). 
Distinct surface molecules are also differentially expressed in different subsets of 
neurons, which may indicate their roles in forming functionally distinct circuits (Fig. 
2.12J-L). Among them, Fas3 appears to co-express in a large proportion of Sp1 
neurons, regardless of their low degree of co-expression in the INP and GMC stages 
(compare Fig. 2.12D vs J). To validate that Fas3 protein is translated in neurons of this 
developmental stage, we used a Fas3 antibody to stain our novel type-II lineage 
reporter fly and found that it labels neurons in the DM1-3 lineages that form neurite 
bundles across the commissure (Fig. 2.12M, N). It is plausible that the expression of 
Fas3 in INP may play a role in enabling some of the neural progenies of DM1-3 to either
form these axonal bundles or for them to find their final targets across the commissure 
early on in the neural maturation process. 
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Fig. 2.13: Marker genes of subtype-specific immature/maturing neurons
(A) UMAP plot with automatic cluster assignments (resolution = 0.6). (B) The top 10 
marker genes identified for each of the neural clusters in this scRNA-seq dataset.
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Drosophila type-II neural lineages as a model system to study complex 
neurogenesis processes
To enable the brain’s complex functions, vastly diverse neuronal types need to be 
rapidly generated at a very large scale during development. To reveal how neural stem 
cells populate the developing brain, efforts have been made to identify cell types and 
their lineage relationships. For instance, focuses on neurodevelopment in mouse (Habib
et al., 2017; Han et al., 2018; Ponti et al., 2013; Saunders et al., 2018; Soldatov et al., 
2019), human brain tissues (Habib et al., 2017) and the developing human prefrontal 
cortex (Zhong et al., 2018) revealed intermediate stem cells (and critical genes 
involved) as an important mechanism for rapid cortical expansion. Underlying this rapid 
and diverse differentiation process is the constant change of gene expression profiles in
all cells. However, the molecular mechanisms that lead to functionally distinct neurons 
in the mammalian brain remain challenging to describe in detail. This is because, on the
one hand, neuronal fate determination involves many genes, and on the other hand, 
neural progeny cells originating from distinct lineages undergo rapid migration, which 
leads to their intermingling nature in space.
Although they are the minority (8 stem cells per hemisphere) in the Drosophila central 
brain, the Drosophila type-II neural lineage has a neurogenesis process analogous to 
the mammal’s rapid cortical expansion (Homem and Knoblich, 2012). Compared to their
mammalian counterparts, the Drosophila type-II neural lineage has the advantage of 
being non-migrating in the larval stage. With proper labeling, type-II progeny cells of the 
same lineage can be identified as a segregated cell cluster. Importantly, the cells' 
spatial relationship within a cluster serves as a considering factor when determining the 
age and maturation stage of these cells (Boone and Doe, 2008; Homem and Knoblich, 
2012). The small stem cell pool and mammal-like lineage composition make the 
Drosophila type-II neural lineage an attractive model to study the complex brain 
development process. In addition, many important genes and signaling pathways are 
conserved throughout evolution (Homem and Knoblich, 2012; Mariano et al., 2020; 
Ogawa and Vallender, 2014), which makes revealing the molecular mechanisms of 
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Drosophila type-II neuron differentiation a meaningful primer to study the human 
analogs in the outer subventricular zone.
Summary of this work
In this work, we used targeted single cell transcriptome analysis to advance our 
understanding of the Drosophila type-II neuron differentiation process. After initially 
separating the transcriptomes of the type-II neuroblast derived cells from those labeled 
in the optic lobes, we show that pseudotime analysis techniques can be used to define 
a maturation axis and extract putative marker genes that specify the INP, GMC, 
immature neuron and mature neuron differentiation stages. Broadly expressed, not 
limited to the type-II NB progenies, these marker genes of different maturation stages 
indeed form intersectional patterns that represent the spatial organization of the 
neurogenesis progress in the larval brain. Compared to previous antibody-based and 
gene manipulation-based screening strategies, scRNA-seq data permits a high-
throughput assessment of the whole gene expression profile to rapidly identify 
candidate genes for functional study. For instance, in the past, Hey has been shown to 
mark one of the two immature neurons derived from the final cell division, and its role is 
exclusive as an inhibitor of Notch signaling in this immature neuron (Monastirioti et al., 
2010). From our scRNAseq analysis, E(spl)m6-BFM, a member of the enhancer-of-split 
family of transcription factors (Lai et al., 2000), and Rbp, a rim-binding protein 
responsible for synaptic homeostasis and neurotransmitter release (Liu et al., 2011; 
Müller et al., 2015) are exclusively up-regulated in only the transient immature neuronal 
differentiation state directly after GMC division. These two marker genes can be used to
guide the exploration of Hey- immature neurons in future studies. Functional knock-outs
of these two genes will be critical to understanding their function in newly-born neurons 
as it pertains to their maturation and any early functional role they may play in the 
developing brain.
Further higher-resolution clustering of the INP and GMC cells identified 
transcriptomically correlated subclusters between these two stages, which supports the 
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idea that parallel maturation transitions happen at the same developmental time point. 
However, scRNA-seq data alone cannot distinguish whether these parallel transitions 
are due to the co-existence of earlier and newly born INPs in all NB lineages or due to 
the intrinsic differences among NB lineages. We therefore in situ profiled the marker 
genes selected from the scRNA-seq selected candidates and restored their missing 
spatial information that indicates the maturation stage as well as the NB lineage identity.
In addition, combined with prior knowledge, whether a marker gene is expressed in 
younger or earlier born INPs can also be speculated. Our findings conclude that Sp1 is 
expressed in the young INPs of nearly all NB lineages, whereas TfAP-2 and Fas3 
express in older INPs belonging to specific NB lineages. Interestingly, we found that 
Sp1 and TfAP-2 expressed not only in neural progenitors but also in maturing neurons. 
These transcription factors seem to intermingle with the NB lineage-specific D/grh/ey 
cascades in the INP stage, but eventually differentiate into completely exclusive neuron 
populations. Finally, higher-resolution clustering of neurons in our scRNAseq dataset 
revealed that transcription factors and surface molecules are predominant markers for 
distinct neuronal subtypes at the 3rd instar larval stage. This implies that most neurons 
of the type-II NB progenies have not started to gain their differentiated functions at this 
stage of development.
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Fig. 2.14: A Drosophila type-II neuronal fate specification model illustrates the 
complex molecular network that determines the neural differentiation process
Despite its small scale and apparent simplicity, the complex interplay of molecular 
factors that vary along the differentiation state, lineage identity, and progenitor cell 
division number axes are responsible for determining the fate of each cell derived from 
the type-II neuroblasts of Drosophila. In this diagram, some of the most prominent 
molecular factors from the literature or identified and validated in this work are shown to 
occupy different domains along these three axes. Multi-time-point analysis and in situ 
validation will enable us to continue to fill in the blanks and develop a more complete 
roadmap of the type-II neurogenesis process across development.
Combining in silico scRNA-seq analysis and in situ mRNA imaging, we discovered 
many transcription factors and surface molecules that potentially play important roles in 
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generating neuronal subtypes in an NB-specific, INP-specific, or function-specific 
manner. These discoveries helped us to gain a comprehensive understanding of the 
molecular landscape along all three major neural developmental axes that define a 
cell’s progenitor lineage identity, progenitor cell division number, and differentiation 
state (Fig. 2.14). This model provides a general guidance for biologists to disentangle 
the differentiation process in complex systems beyond the Drosophila brain.
Challenges and opportunities
We sequenced approximately 4000 cells that were neurons originating from 8 
Drosophila type-II neuroblast lineages (16, if we assume no symmetry across the two 
central brain lobes). With low-resolution clustering, we identified 13 molecularly distinct 
neural subtypes. Increasing the clustering resolution just a bit higher we could identify 
more than 20 that are still distinct (data not shown). Similarly, as we show with the 
INPs/GMCs in our dataset, a low-resolution clustering can often mask the cellular 
diversity that is present in the system. As we know that each type-II neuroblast 
generates approximately 38 INPs throughout their developmental lifespan (Bayraktar et 
al., 2010; Bello et al., 2008), the presented clustering in this paper only captures part of 
the INP diversity. One straightforward thought is to increase the number of sequenced 
single cells so that higher clustering resolution may eventually reveal even the most 
subtle differences between each of the hundreds of INPs in the type-II system. 
However, as transcription factor cascades involved in INP division/maturation intertwine 
with those involved in NB specification and differentiation, we expect that the INP 
heterogeneity can be untangled somewhat using a higher clustering resolution but still 
fails to provide us with a coherent view of the complex lineage, maturation, and 
differentiation landscape we are attempting to characterize. These issues highlight the 
challenge of deconvoluting the INP maturation, NB lineage, and differentiation state 
axes and the need for a holistic, integrated approach to experimental design and 
subsequent bioinformatic analysis.
The data we have presented here were collected at a single developmental time-point 
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(late third instar), but we know that type-II neurogenesis precedes and continues after 
this stage. Repeating these scRNA-seq experiments at more developmental time-points
will reveal more in what order molecularly-defined neural subsets are generated. Using 
recently developed analytical techniques to “stitch” these multi-time-point datasets 
together (Lin et al., 2019; Tran and Bader, 2019) will be advantageous to align all the 
cells along a unified developmental time axis. To overcome the limitation of the R9D11-
Gal4 driver, which does not label neuroblasts nor the fully mature neurons, a permanent
labeling strategy, similar to the one used in (Bayraktar et al., 2010) but covering all 
lineages more reliably for FACS, is required. More critically, such permanent labeling 
needs to be paired with technologies that provide single-lineage specification resolution,
such as the introduction of single-neuroblast lineage barcoding techniques. Genetic 
constructs based around CRISPR-Cas9 (Raj et al., 2017; Spanjaard et al., 2018) and 
the Cre/Lox system (Kalhor et al., 2018; Pei et al., 2017; Weber et al., 2016) have been 
developed for this purpose, although which exact lineage was labeled by a particular 
barcode was still unknown. The introduction of a spectrally unique barcode for each 
neuroblast lineage, in a similar vein to the recently developed Bitbow lineage tracking 
strategy (Li et al., 2020; Veling et al., 2019), would be advantageous as they can 
provide direct in situ evidence for neuroblast lineage identity.
Finally, our work identifies several transcription factors that are specifically expressed in
subsets of cells of the type-II neuroblast progenies. Our in silico and in situ results 
showed that their expressions are either constrained to particular developmental stages,
or in subsets of cells that are born in different orders. It would be desired to perform 
follow up experiments to reveal whether these transcription factors play important roles 
in specifying the terminal fates of type-II neuronal subtypes.
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Chapter 3
Making Single-Cell RNA-Seq Analysis Accessible For All
What does it take to complete an scRNA-seq experiment from start to finish?
Fig. 3.1: Diagram outlining steps in a typical scRNA-seq experiment
A typical single-cell RNA-seq (scRNA-seq) experiment can be broken down into 4 main 
steps Cell prep involves collecting animals, dissecting out the tissue(s) of interest, and 
dissociating them into a single-cell suspension via a combination of chemical and 
mechanical tissue disruption techniques at an experimentally optimized temperature 
that balances enzyme activity with cell viability. Cell sorting, an optional step, ensures 
that only cells labelled with a genetically encoded or antibody-added dye are collected 
for downstream processing. Capturing the mRNA and sequencing it are at the core of 
these experiments, with many thesis written in recent years on methods for improving 
capture efficiency, experimental scale, and sequencing fidelity. Finally, data analysis 
(both aligning the sequencing reads to the transcriptome and processing the gene-by-
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cell counts matrix) enables researchers to ultimately form and test hypotheses about the
cell populations they sequenced.
Though they are by no means the most challenging type of experiment to perform in a 
cell biology lab, single-cell RNA-seq (scRNA-seq) experiments are complex, relying on 
the intersection of many experimental and analytic techniques in order to generate and 
test meaningful hypotheses about populations of cells at the mRNA expression level. As
I show in Fig 3.1, these techniques roughly span 4 domains: sample/cell prep, cell 
sorting/isolation, single-cell mRNA capture and sequencing, and data analysis. Here I 
will describe some of the literature surrounding each of these domains, ending in the 
data analysis domain which I will describe in greater detail throughout this chapter.
Tissue dissociation
Unlike newer whole tissue spatial transcriptomics assays (Asp et al., 2020; Cho et al., 
2021; Liu et al., 2020; Rodriques et al., 2019), traditional high-throughput scRNA-seq 
methods typically require that tissues be dissociated into single-cell suspensions before 
processing (Macosko et al., 2015; Picelli et al., 2014; Ziegenhain et al., 2017). This is 
fundamentally due to the fact that in order to capture and process mRNA from a single 
cell, a single cell must be separated from the rest of its cohort, otherwise mRNA from 
multiple cells would be combined and any downstream analysis of those mRNA 
molecules would be cofounded (i.e. we would not know which cell contributed which 
mRNA molecule to the pool of mRNA). 
Tissue dissociation methods aim to take an intact tissue, such as the developing larval 
brain from Drosophila, and by some combination of enzymatic and mechanical action 
break that tissue up into its component cells. In most cases, this is done without 
chemical fixation, as viable dissociated cells are the desired end product (though some 
mRNA can be extracted from fixed tissues; see for example (Alles et al., 2017; 
Denisenko et al., 2020)). As different tissues in different organisms are made up of 
different component cell types, dissociation protocols vary wildly, each aiming to 
improve the yield and health of viable cell suspensions (Pretlow and Pretlow, 1987). In 
the larval and adult Drosophila brain others have attempted to generate viable single 
cell suspensions of neuroblasts and neurons for FACS and scRNA-seq studies (Croset 
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et al., 2017, 2018; Davie et al., 2018; Harzer et al., 2013; Li et al., 2017). I aimed to 
improve upon these protocols, with the specific goal of increasing the yield of neurons 
from the tightly-connected ventral nerve cord (VNC) to ensure fair representation of 
cells from both the CNS and PNS for future studies. Using a trh-Gal4 genetic driver line 
crossed to our UAS-hH2B::2xmNG reporter line to label all serotonergic neurons in the 
developing larval brain (84 in total, with cell bodies residing primarily in the VNC (Li et 
al., 2020b)), I systematically dissociated individual brains and counted the number of 
identifiable mNG+ cells in single wells of a 96-well dish post-dissociation, testing a 
variety of different enzymatic and mechanical dissociation conditions to obtain a 
protocol yielding the maximum number of viable neurons. This optimized protocol is 
available in greater detail in appendix A3, and intermediate optimization steps are 
characterized in Fig 3.2.
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Fig 3.2: Larval brain dissociation optimizations
The number of single cells expressing mNG after dissociation from single trh-Gal4 x 
UAS-hH2B::2xmNG brains under a variety of dissociation conditions. Colored bars 
represent the mean of n=3 independent replicates (grey circles) per condition. 1mM 
CaCL2 can be replaced with 15uM ZnCL2 as both positive ions activate collagenase with 
similar effectiveness (and Zn+ is generally less toxic to neurons).
In general, the combination of the proteases papain and collagenase type I, elevated 
temperature, and periodic mixing led to a reproducible maximum in yield of labelled trh-




In order to perform targeted single-cell sequencing of specifically labelled 
subpopulations of cells, cell sorting/isolation techniques are required. Some methods 
have been developed to sort cells based on their mass/size using centrifugal forces 
both in test tubes (Rizzardi et al., 2016) and in microfluidic chips (Lin et al., 2017). 
Others utilize magnetic particles coated with antibodies that recognize cell type-specific 
surface antigens (Miltenyi et al., 1990). 
Arguably the most flexible and popular method of cell selection is fluorescence activated
cell sorting (FACS), wherein cells are individually passed in front of a laser(s) and their 
size (side-scatter), complexity (back-scatter), and fluorescent activity are recorded. 
Based on user-defined ‘gates’ around these metrics, cells with specific characteristics 
can be isolated apart from their cohort in rapid succession (Herzenberg et al., 2002). 
Recent studies (Berger et al., 2012; Harzer et al., 2013), including this work, have made
use of genetic labelling schemes to incorporate bright fluorescent proteins into cells of 
interest in order to make them sortable on FACS machines. Surface staining of cell 
suspensions with dye-conjugated antibodies is also common (Herzenberg et al., 2002). 
Though high flow rates in FACS machines are thought to induce some cellular stress, 
gene expression is only minimally affected by FACS (Richardson et al., 2015), making it
suitable for scRNA-seq and related studies. 
mRNA capture and sequencing
After tissues have been dissociated and specific cellular subpopulations have been 
(optionally) isolated, the single-cell mRNA capture process can begin. Many methods 
have been developed to meet this need, falling into four major categories: plate-based 
methods, droplet-based methods, combinatorial split-and-pool methods, and hybrids of 
these aforementioned categories. Here I will briefly describe the general biochemical 
principles that all of these methods rely on before briefly detailing the working principles 
behind two of the more popular categories.
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Despite some biochemical similarities, RNA cannot be recognized by the taq DNA 
polymerases used in PCR reactions, thereby making it impossible to amplify without first
making a cDNA copy of the RNA template. In bulk RNA-seq reactions this is done by 
extracting RNA from many cells in a single reaction vessel and mixing this RNA with a 
reverse transcriptase enzyme and mRNA capture oligos - single-stranded DNA oligos 
the contain both a poly-dT region (complementary to the poly-A region at the 3’ end of 
mature mRNA) and a PCR handle. Coupled with a template-switching oligo which can 
add a second PCR handle at the 5’ end (Gilboa et al., 1979), this reaction results in the 
generation of a single stranded cDNA molecule that contains a sequence 
complementary to that of the template mRNA.
Fig. 3.3: A simplified view of a reverse-transcription reaction
The first step in most RNA-seq experiments after RNA extraction, a capture oligo that is 
partially complementary to the poly-A tail of the target mRNA is mixed with a reverse 
transcriptase (RT enzyme) and template switching oligo (TSO) in order to generate a 
stable cDNA copy of the template mRNA that is ready for PCR amplification. 
What differentiates single-cell mRNA capture chemistries is the addition of a unique, 
PCR-amplifiable ‘cell barcode’ (and optionally a Unique Molecular Identifier/UMI) to 
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each mRNA template. These sequences are typically added to the poly-dT capture oligo
as in (Macosko et al., 2015), though they can alternatively be added through direction 
ligation, as in (Hochgerner et al., 2017), or in later sequencing library preparation steps 
using unique sequencing library adapters, as in (Picelli et al., 2014). At a high level, the 
end result is the same - each mRNA molecule is uniquely tagged by a UMI and a cell 
barcode that is unique to each cell but shared by all mRNA from that cell.  
Fig. 3.4: An RT reaction with cell barcodes and UMIs
The addition of Unique Molecular Identifier (UMI, a stretch of random nucleotides 
unique to each capture oligo) and Cell Barcode sequences (a stretch of random 
nucleotides unique to each cell) to the poly-dT capture olgo, in combination with single-
cell isolation techniques, biochemically enables assignment of each mRNA molecule to 
a cell of origin. UMIs enable correction for PCR amplification biases by providing a 
unique identifier for each molecule before those molecules are amplified by PCR in 
preparation for sequencing - important for accurately modelling gene expression levels 
in scRNA-seq experiments.
The addition of cell barcodes to poly-dT capture probes is not particularly useful without 
physically isolating individual cells from one another in separate reaction vessels, in 
order to react capture oligos containing one cell barcode with mRNA from only one cell. 
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The simplest (and typically most costly) scRNA-seq protocols involve sorting single cells
into individual wells of multi-well PCR plates that can be assigned unique cell barcodes 
at the final sequencing library preparation step (Hagemann-Jensen et al., 2020; Picelli 
et al., 2014). These techniques benefit from a massive surplus of reaction volume and 
the ability to capture and process full-length mRNA transcripts, making them powerful 
for the detection of rare mRNAs and isoforms. 
To massively improve cell throughput, microfluidic droplet-based scRNA-seq methods 
have been developed and popularized through both in-house and commercial solutions 
(Habib et al., 2017; Macosko et al., 2015; Ziegenhain et al., 2017). These methods co-
encapsulate single cells with beads containing poly-dT capture oligos inside of water-in-
oil droplet emulsions at a rate of thousands of droplets per second. This droplet 
emulsion can then be placed in a single reaction vessel (tube), thousands of cells now 
reacting independently with capture oligos from their own unique bead (as the oil 
prevents cross-talk between droplets). Without a doubt the most popular solution thanks
in part to commercialization work by 10X Genomics, more than 2500 papers have been 
published using technologies of this type since 2015 (Saxonov, 10X Genomics Investor 
Presentation, 2021). 
Fig. 3.5: Simplified diagram of a ‘Drop-seq’-style single cell mRNA capture device
Beads (large circles) are co-flowed with cells (small circles) and pushed from left to right
through the microfluidic device. Droplets are generated by introducing an inert oil from a
third channel at a high flow rate and pushing the mixture through a narrow junction, 
essentially ‘pinching off’ the bead/cell mixture and forming droplets separated by oil. 
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Each droplet then is its own independent reaction vessel, and as cells are lysed in each 
droplet their mRNA will hybridize to capture oligos provided by each bead, with oil 
preventing mRNA from transferring between droplets.
After capturing, barcoding, and generating amplified cDNA copies of the mRNA from 
each cell, molecules need to be sequenced. With the advent of next-generation 
sequencing technologies in the mid-2000s coming about first by the development and 
commercialization of sequencing-by-ligation (Shendure et al., 2005) technologies and 
subsequently launched forward by the development and commercialization of 
sequencing-by-synthesis (Bentley et al., 2008) technologies (Illumina-style sequencers),
generating more than 400 million high-fidelity sequencing reads from a scRNA-seq 
experiment is now routine. Extremely powerful for assaying gene expression at the 
mRNA level, the main limitation of these popular Illumina-style sequencers is their short 
read lengths, with most scRNA-seq libraries generating data from <100bp of each 
captured mRNA molecule, though reads as long as 600bp are commercially supported 
(though significantly more costly). Since most mRNA transcripts are larger than 2kb, 
short reads can limit the ability to detect alternatively spliced mRNA molecules coming 
from the same gene locus, making RNA-velocity (La Manno et al., 2018) and isoform-
specific (for example, (Joglekar et al., 2021)) analyses challenging. 
Data analysis - sequence alignment
Typical scRNA-seq datasets comprise more than 400 million sequencing reads, each of
which might represent a portion of an mRNA transcript. In order to determine which 
gene each sequencing read corresponds to, the first step in most scRNA-seq data 
analysis pipelines is to align/map reads to the transcriptome of the organism(s) of origin.
Though computationally taxing, many tools are available to accomplish this task for 
most organisms, with STAR (Dobin et al., 2013; Kaminow et al., 2021), CellRanger (10X
Genomics), Salmon (Patro et al., 2017), and Kallisto-bustools (Bray et al., 2016; 
Melsted et al., 2021) being popular options. A great deal of effort has gone into the 
development and optimization of these tools, and it is beyond the scope of my thesis to 
describe them in detail. Irrespective of their algorithmic differences, each tool can 
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generate a so-called ‘counts matrix’, with unique cell barcodes and gene names making
up the rows/columns, respectively. Gene expression values in the form of counts 
populate the matrix, representing the (typically integer) number of unique mRNA 
transcripts belonging to each specific gene from each unique cell. 
Fig. 3.6: A diagram of a typical scRNA-seq counts matrix
Unique cell IDs (cell barcodes) make up the row labels, while gene IDs make up the 
column labels. Integer counts populate the matrix, representing the number of 
sequencing reads that correspond to a specific gene in a unique cell. In scRNA-seq 
protocols that include unique molecular identifiers (UMIs), these gene expression 
counts represent truly unique mRNA molecules. Without UMIs, these gene expression 
counts may include PCR duplicates, over-estimating the true mRNA expression level.
Data analysis - secondary/downstream analysis
On its own, the cell-by-gene counts matrix is not particularly useful. An attempt to 
represent the mapping between raw sequencing reads to gene expression levels in 
thousands of cells at a time, these matrices are large, limited by mRNA sampling rates 
(so-called ‘dropouts’ leading to extremely sparse matrices (Cao et al.; Svensson, 
2019)), and difficult to interpret on their own. Methods from machine learning and linear 
algebra have been co-opted to help researchers filter and reduce the complexity of 
these datasets, and here I refer to this collection of methods as secondary or 
downstream scRNA-seq analysis (in contrast to sequence alignment). 
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Fig. 3.7: A typical secondary/downstream scRNA-seq analysis pipeline/protocol
Dashed boxes/arrows indicate methods that are applied to transform the data from a 
raw counts matrix into a set of interpretable plots and metrics that researchers can use 
to draw conclusions about how heterogeneous their cell population(s) are and what 
genes are expressed to differentiate these cell types from one another. With more than 
10 transformation steps, each with adjustable parameters, these protocols can be 
challenging to work through. Solid arrows here indicate dependencies; for example, 
UMAP and cell type clustering analysis both require that cell neighborhood and PCA 
representations of the data be computed, but do not depend on one another. 
Developing a Multi-informatic Cellular Visualization tool (MiCV) to make 
secondary scRNA-seq analysis accessible to all
Though many toolkits have been developed to perform the steps in a typical scRNA-seq
secondary analysis pipeline (Dhapola et al., 2021; Li et al., 2020a; Lopez et al., 2018; 
McCarthy et al., 2017; Satija et al., 2015; Wolf et al., 2018), little work has been done to 
provide easy-to-use graphical applications based on these toolkits. This makes scRNA-
seq analysis challenging for many researchers whose expertise are not in coding with 
advanced programming languages like R and python, but in their experimental 
techniques and deep knowledge of the literature context surrounding their scRNA-seq 
data. This lack of graphical tools does not come as a great surprise, as developing user-
facing graphical applications requires a tremendous amount of programming effort 
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largely on for rudimentary tasks of little academic significance (for example, code to 
place a button on a screen at a specific location, and related code to make that button 
trigger an action when pressed, but only when a user is logged in, and so forth). 
Typically such programming tasks stay in the commercial realm, but companies starting 
from scratch in the area of scRNA-seq secondary analysis often ‘reinvent the wheel’ 
instead of building on top of the great open source academic developments outlined 
previously. With this in mind, I developed MiCV (Michki et al., 2021), a web-based 
graphical tool that enables researchers with no programming experience to leverage 
these toolkits for their own analyses. Building on top of scanpy (Wolf et al., 2018), a 
python-based scRNA-seq secondary analysis toolkit, alongside many other open source
libraries, MiCV exposes researchers without any programming experience to an 
analysis pipeline that keeps up with trends in the rapidly developing bioinformatics field 
and makes it possible for a single push of a button to generate publication-ready plots 
and analyses. A mix of interactive and static plots and reports make iterating on cluster 
assignments, marker gene identification, and pseudotime analyses possible in minutes 
instead of days. 
Here, I will outline the main steps in a typical scRNA-seq secondary analysis pipeline, 
and outline alongside each step some features of the MiCV web tool that allow users to 
interact with this pipeline as they see fit. 
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Fig. 3.8: The first page of the MiCV web tool
MiCV’s post-login page provides options to upload data or load previously-analyzed 
datasets. A status panel on the right informs users about what operations, if any, are 
currently on-going in the background or have been completed previously. Users are 
encouraged to not change default pipeline parameters by only being provided with an 
‘Analyze data’ button on this page, with more advanced controls hidden away in a 
separate ‘Advanced’ tab. This makes the tool easier to use (there is only one button to 
press to move through the entire secondary analysis pipeline), improves reproducibility 
(by having many users make use of the same default parameters), and still enables 
more advanced use-cases without the need for other tools.
Filtering the counts matrix
The first step in most scRNA-seq downstream analysis pipelines involves filtering the 
counts matrix. Here, cells that express too many or too few genes/UMI counts/reads are
removed from the dataset, likely representing ‘doublets’ (cells that were physically co-
encapsulated into the same reaction vessel, and thus have the same cell barcode) and 
low-quality cells and/or cell barcodes with only background mRNA, respectively. So-
called ‘knee-plots’ are often used to determine lower bounds for this cell filtering step; 
when cell barcodes are ranked based on the number of UMI counts they were assigned,
a sudden dropoff is usually identifiable. Cell barcodes with fewer UMIs than this 
inflection point (knee) are typically believed to represent low quality cells and 
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background RNA, though some debate in the field remains as to how strictly this cutoff 
should be followed (Lun et al., 2019), as some cell barcodes with very few UMIs may 
represent true cell types that simply express far less mRNA than others in the dataset. 
Fig. 3.9: A ‘knee-plot’, showing the number of unique mRNA transcripts (UMIs) 
associated with each cell barcode
When plotted on log-log scales, a sudden inflection point can typically be identified 
(vertical dashed line); cells to the right of this line are considered low-quality or 
representative of background mRNA, and are thus removed from the dataset. Cells with
far more UMIs than the median may also be filtered, though this cutoff point is much 
more arbitrary and relies heavily on knowledge about the cell type distribution the data 
represents (for example, actively proliferating cells may express far more mRNA than 
quiescent cells, and so a wide range of UMI counts should be expected). Data in this 
plot comes from the 10Xv2 type II scRNA-seq experiment described in chapter 2, and 
was generated using UMI-tools (Smith et al., 2017).
Genes are also filtered, removed here if they are expressed in too few cells for 
statistical comparisons to be meaningful. In practice, many tutorials recommend 
removing genes expressed in fewer than 2-5 cells (Satija et al., 2015; Wolf et al., 2018),
though cutoffs expressed as a fraction of the cell count (for example, 0.01% of all cells) 
may be more appropriate for datasets of varying size. Using MiCV, these filtering 
parameters can be modified from their preset defaults using slider bars that indicate 
relevant ranges of parameter values for users to explore.
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Figure 3.10: MiCV interface for modifying cell/gene filtering parameters
Defaults are marked along the slider bars, and currently selected values are indicated in
the text above each slider to remove ambiguity and improve reproducibility. Similar 
interfaces are provided for selecting the number of highly variable genes, the number of 
neighbors in the cell-cell neighborhood network, and the clustering resolution.
Converting the counts matrix into a gene expression matrix (normalization)
In order to model the noise distribution of this filtered counts matrix and stabilize its 
variance, a variety of gene expression normalization strategies are used. Typically, 
estimating size factors on a per-cell basis, using these size factors to normalize each 
cell to have the same number of total counts (conversion to counts-per-million/CPM), 
and a log-transforming the data (ln(1+CPM)) accomplishes this goal (Love et al., 2014) 
and has been used before to compare bulk RNA-seq experiments. Other methods have 
also been proposed, though their increased complexity has limited their adoption (Grün 
et al., 2014; Hafemeister and Satija, 2019; Lopez et al., 2018; Svensson et al., 2020), 
as have debates in the field about which noise model(s) represent the true noise 
observed in scRNA-seq data originating from droplet-based experiments (Svensson, 
2019). In MiCV, I opted to use size-factor based normalization with log-transformation, 
and no user-modifiable parameters are exposed to the user in order to increase 
reproducibility and simplicity.
73
Fig. 3.11: A diagram showing the mRNA expression matrix
This is the counts matrix after filtering cells, filtering genes, normalizing expression 
using cell size-factors, and log-transforming the data. I call this matrix the ‘expression 
matrix’, in contrast to the counts matrix from before, as the values that populate this 
matrix can be fairly compared across cells and can be brought forward for further data 
dimensionality reduction and processing.
Reducing data dimensionality and identifying putative cell-type clusters
This filtered gene expression matrix is still large and sparse, making the identification of 
cell types/clusters challenging both by eye and with the help of clustering tools (Traag et
al., 2019). To overcome this challenge, dimensionality reduction techniques are 
employed to drastically reduce the dataset dimensionality. Principal component analysis
(PCA) is the most commonly used technique in this class, being closely related to 
familiar eigenvector/eigenvalue decomposition and/or singular value decomposition 
operations used in a range of linear algebra techniques (Pearson, 1901). Other tools 
such as scVI (Lopez et al., 2018; Svensson et al., 2020) reduce dimensionality by 
training neural network models to identify the ‘latent space/manifold’ that the gene 
expression data exists in/on, and data diffusion models such as those proposed by (van
Dijk et al., 2018) similarly reduce data down into ‘diffusion components’ that represent 
the latent gene expression space. Though potentially more accurate, their increased 
complexity and computational expense make them less popular, especially for basic or 
first-passes at scRNA-seq secondary analysis.
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Intuitively, we can think of PCA as identifying the primary weighted sets of genes that 
describe maximal variance in the dataset. For instance, if the genes D, grh, and ey in an
scRNA-seq dataset from the fruit fly were responsible for contributing the most to 
differences (variances) in cell transcriptomes, then they might be represented in the first
principal component (PC) of the PCA-reduced dataset (with some weights attached to 
each gene to represent their relative contributions to that variance). Genes that 
contribute very little to cell variance (a classic example is Actin, found in nearly all cells) 
will be represented in each PC with extremely small weights, denoting their relatively 
small contribution to cell-by-cell differences in gene expression (despite being a very 
highly expressed gene overall). While a variable number of principal components can 
be used, in MiCV we keep the m=50 top PCs, which represent the majority fraction of 
variance in most scRNA-seq datasets. This parameter is informed in large part by 
tutorials provided by the authors of scanpy (Wolf et al., 2018) and may be made user-
adjustable in future versions of MiCV. 
Fig. 3.12: A diagram of a PCA-reduced scRNA-seq dataset
Cells (represented as circles) are placed in an m-dimensional PCA space (here, m=50, 
though only 3 axes are represented graphically), where each cell’s position along the m 
axes represents their gene expression state. Before PCA, each cell’s gene expression 
state was represented by an n-dimensional space, where each dimension represents 
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the expression of one gene. Since for most organisms and scRNA-seq experiments 
n>10,000>>m, reducing the dimensionality of the gene expression data massively 
reduces noise and improves computational efficiency at the cost of some information 
loss during neighborhood identification and low-dimensional data embedding.
In order both the cluster cells based on their gene expression state and represent our 
now 50-dimensional data in 2D (or 3D) projections, a cell-cell neighborhood graph 
needs to be generated. Graph generation algorithms attempt to characterize the 
abstract structure of single-cell gene expression data by drawing edges between cells 
that have similar gene expression characteristics. Many algorithms to build this graph 
exist (Goldberger et al., 2004), though the algorithm proposed and implemented 
alongside the UMAP algorithm is commonly used (McInnes et al., 2018). While a bit 
arcane, this network description of an scRNA-seq dataset makes identifying putative 
cell subtype clusters possible. The main parameter that can be varied in this algorithm 
is k, the expected number of nearest neighbors for each cell. Intuitively, we can think of 
this parameter as estimating the size of the smallest cell type cluster (based on gene 
expression) in any given scRNA-seq dataset. Extremely large datasets may benefit from
the selection of a higher value for k, due to their relatively large number of cells; 
however in practice a small value such as k=20 will result in similar cell-type clustering 
and UMAP projection results as a larger value, and is the default in MiCV and other 
pipelines (Wolf et al., 2018), though in MiCV this is a user-editable parameter.
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Fig. 3.13: A diagram of a cell-cell network graph
Cells are represented by circles, and the network is represented by edges of varying 
weights between cells projected in PCA-space. Light, dashed lines represent 
particularly weak connections between cells, indicating that two cells are likely not 
‘similar’ enough to be clustered/projected together. 
In order to easily visualize the complex, high-dimensional gene expression data 
encapsulated by the cell by gene expression matrix, low (2 or 3) dimensional 
‘embeddings’ of the data need to be generated. Intuitively, what we aim for is a 2D plot 
where cells that are ‘similar’ in their gene expression levels are nearby to one another in
2D space, and cells that are very ‘dissimilar’ are farther away. Though made up of more
than 10,000 dimensions (1 for each gene), methods such as tSNE (van der Maaten and
Hinton, 2008) and UMAP (McInnes et al., 2018) are popular among single-cell 
researchers for reducing their high-dimensional gene expression data into interpretable 
low-dimensional plots, with UMAP gaining widespread adoption due to its increased 
stability. In MiCV, only UMAPs are supported, and no parameters are changed from the 
defaults provided by the scanpy and UMAP-learn libraries (McInnes et al., 2018; Wolf et
al., 2018). 
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Fig. 3.14: A diagram of a typical 2D UMAP projection
Cells are more compactly clustered in 2D-space based on their local neighborhood 
network connections, which UMAP (and tSNE) algorithms can take into consideration 
when defining a high-to-low dimensional embedding of scRNA-seq data. 
Though low-dimensional embeddings can impart some visual ‘structure’ to complex, 
high-dimensional scRNA-seq datasets, robustly identifying cell-type clusters requires 
the use of higher-dimensional representations of the data. The leiden/louvain clustering 
algorithms (Traag et al., 2019), used by default in scanpy and MiCV, walks the 
previously calculated cell-cell neighborhood network and identifies groups (clusters) of 
cells that are tightly connected in this graph. These well-connected groups are 
separated out as cell-type clusters, enabling us to do pseudo-bulk comparisons 
between putative cell types. We commonly label each cell in UMAP projections with 
colors that correspond to each cell-type in order to visualize where specific cell-types 
project to in a low-dimensional embedding and to build an intuition about how similar 
certain cell-types may be. The leiden algorithm typically can accept a user-provided 
resolution parameter that can bias the number of cell types that are identified. Higher 
values (>1) for this parameter will generate more, finer-grained clusters than the default,
and smaller (<1) values will generate fewer, coarse-grained clusters. Both can be 
informative about cell type diversity, as low resolution clustering can be used to identify 
primary cell types (for example, ‘neurons’ vs. ‘glia’) and high resolution clustering can 
further break down these large groups into secondary cell types (for example, 
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‘excitatory neurons’ vs. ‘inhibitory neurons’). In MiCV, this is a user-definable parameter 
that can be used to rapidly iterate on the clustering resolution.
Fig. 3.15: Cell type clustering in MiCV
Left: A post-clustering diagram of the cell-cell network in PCA space. The network has 
been pruned of low-weight connections by the clustering algorithm, and separated 
networks of cells are labelled as different cell types (colors). Many graph clustering 
algorithms are used in network analysis, though the leiden algorithm (Traag et al., 2019)
is popular for scRNA-seq data. Right: A section of the MiCV interface devoted to 
changing the clustering resolution parameter. Without needing to perform any PCA, 
neighborhood, or UMAP calculations, users can rapidly change the clustering resolution
and view cluster assignments on a 2D UMAP projection by using a slider bar interface.
Identifying what makes each cell-type unique (marker gene analysis)
One of the first questions we can ask when presented with clustered scRNA-seq data is
“What makes these clusters unique?”. Differential expression (DE) analysis can be used
to answer this question by comparing the gene expression profiles of cells falling into 
each cell type cluster and identifying differentially expressed genes (DEGs) amongst the
cell types clusters. Traditionally, statistical tests such as Student’s t-test or Wilcoxon 
rank-sum tests are used to perform these comparisons and identify genes that are up-
regulated in one putative cell type cluster over the others, considering the distribution of 
gene expression values across cells belonging to each group (Love et al., 2014). Other 
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tests, such as those that overestimate the variance of each group before performing the
Student’s t-test (Wolf et al., 2018), perform logistic regressions (Ntranos et al., 2018), or
use complex (but computationally efficient) cell binning strategies (Vuong et al., 2020), 
are also becoming more common. Regardless of method, these marker genes are 
traditionally viewed in plaintext tables and matrix or dot-plots that can compactly 
represent both the mean expression of each marker gene in the group and the number 
of cells within the group that express the gene at all. In this way, researchers can 
quickly identify genes of interest for specific putative cell types and validate them using 
in situ staining techniques and functional studies to test whether or not specific cell 
types require the expression of specific genes in order to function/develop correctly. 
Marker-gene based cluster analysis is often where a great deal of time is spent in the 
scRNA-seq secondary analysis pipeline, not due to computational complexity but 
instead due to the need to incorporate literature studies in order to add meaningful 
context to marker gene lists. Being presented with a list of 10 gene names, each 
representing a gene that is up-regulated in a specific cell type vs. all others, can be 
challenging to interpret if a researcher is unfamiliar with those 10 specific genes. 
Considering most genomes have well over 10,000 protein-coding genes, the odds that a
researcher will be familiar with any given gene are low. As such, MiCV devotes an 
entirely separate set of tabs/webpages to the marker gene discovery and exploration 
process, enabling researchers to rapidly perform marker gene analysis between 
subsets of putative cell types, download tables and plots representing the results 
therein, plot the expression of individual or groups of genes in UMAP-space, and view 
gene annotations/descriptions from NCBI entrez databases (Maglott et al., 2005) 
without needing to leave the tool or write code themselves. 
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Fig. 3.16: DEG analysis in MiCV
Left: After putative cell type clustering, identifying lists of genes that are up/down-
regulated in each group relative to all others is generally desirable. Dotplots (drawn 
here) use color intensity to indicate the mean expression level of a gene in each group 
and use circle (dot) size to indicate the fraction of cells in each group that express the 
gene at a non-zero level. Right: Since marker gene analysis is so critical to scRNA-seq 
analysis, MiCV devotes an entire tab/webpage to performing and visualizing the results 
of cell type cluster DEG analysis.
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Fig. 3.17: Gene expression exploration in MiCV
In order to rapidly visualize and add literature context to the marker gene discovery 
process, MiCV provides a tab/webpage devoted to plotting gene expression in UMAP-
space (top-left) and as 1-D value distributions/violin plots (bottom). Data from (and 
linkouts to) NCBI entrez databases (top-right) enable researchers to quickly come up to 
speed on the functional characteristics of their genes of interest, previous 
names/aliases, and orthologs found in other organisms. Multicolor gene expression 
plots, like the one shown here in the top-left, are not yet common in scRNA-seq 
secondary analysis toolkits, but have been introduced both in MiCV and other 
interactive tools such as Partek Flow (Partek Inc., 2020) as a way to compare gene 
expression across cell types in a similar manner to how multiplex in situ staining 
experiments are viewed. In MiCV, gene expression values are normalized to have a 
range of [0,1] on a per-gene basis, and so absolute expression levels of each gene are 
lost in these multicolor plots.
Incorporating pseudotime analysis to model developmental trajectories
Though less common than cell type clustering analysis, pseudotime techniques can be 
particularly useful for describing semi-continuous differentiation/degradation processes 
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that may be represented in scRNA-seq datasets. Also called trajectory inference 
methods (Saelens et al., 2019), we can intuitively think of these methods as a way to 
make a line of cells that is ordered based on the set of least changes from cell i to cell 
i+1. Given a starting cell (selected based on the expression of genes at the top of a 
developmental trajectory - for example, high expression of CycE in scRNA-seq data 
from the type II NB system in Drosophila (Michki et al., 2021) which indicates progenitor
status), pseudotime trajectory inference methods search for the cell that is most similar 
in gene expression state to the starting cell and assign it a a pseudotime slightly higher 
than that of the starting cell. Then, the process repeats, searching for the cell that is 
most similar to the most recently placed cell in the trajectory, until all cells are aligned 
along the trajectory. Many different methods exist for fitting these trajectories (Lange et 
al., 2020; Qiu et al., 2017; Saelens et al., 2019; Setty et al., 2019; Street et al., 2018; 
Tran and Bader, 2019), each with their own algorithmic nuances and computational 
speedups. No one-size-fits-all method has made an obvious appearance in the field, 
though Monocle (Qiu et al., 2017) and Palantir (Setty et al., 2019) are popular solutions 
in R and python, in large part due to their comprehensive tutorials and relatively easy-
to-use toolkits. 
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Fig. 3.18: A diagram outlining a simplified view of pseudotime trajectory inference
methods
After selecting a starting cell, pseudotime methods attempt to order cells based on the 
set of fewest changes from cell to cell, ending with the cell(s) that are most dissimilar to 
the starting cell. Some methods also identify branching points in these trajectories; 
points where serious breaks in similarity occur, usually indicating the development of 
unique cellular lineages (not pictured here).
Regardless of the choice of algorithm, one of the main advantages of incorporating 
pseudotime analysis into an scRNA-seq secondary analysis pipeline is the ability to 
estimate gene expression trends across pseudotime - in a sense, giving us a view as to 
how gene expression changes as cells differentiate/degrade/change along the 
trajectory. These gene expression trends can be fit to cells along pseudotime using 
simple binning techniques or smoother, more complex generative additive model (GAM)
fitting (Michki et al., 2021; Setty et al., 2019), and can additionally be generated in 
lineage branch specific manners (if multiple branch points have been identified in the 
pseudotime trajectory). In this way, researchers can view not only the discrete marker 
gene lists that delineate different putative cell types, but also the more continuous gene 
expression changes that oversee complex differentiation processes. These fitting 
methods are somewhat hindered by data non-uniformity (i.e. cells are not necessarily 
uniformly spread along pseudotime, but may ‘clump’ together in certain regions), a 
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recommended reliance on smoothed/imputed gene expression data (van Dijk et al., 
2018) (increasing the risk of over-fitting) and severe dependence on GAM fitting 
parameters (such as the number and degree of splines used to build up the fit line), and
as such gene expression trends should generally be viewed as qualitative measures of 
gene expression changes. In MiCV, these trends are dynamically generated in both 
whole-dataset and branch-specific manners depending on user need using pyGAM 
(Servén et al., 2018).
Fig. 3.19: Pseudotime analysis in MiCV
Top: Cells from the type II scRNA-seq dataset projected in UMAP space and colored by
their pseudotime trajectory placements. Bottom: Gene expression trends along 
pseudotime for 3 genes (Sp1, TfAP-2, Fas3) in the type II scRNA-seq dataset. 
Peaks/troughs for each gene can be readily identified, indicating points in the 
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differentiation trajectory where expression for each gene is high/low. Though plotted 
here in terms of absolute 
Faster iterations of iterative scRNA-seq secondary analysis
A great many scRNA-seq experiments capture a wide variety of cell types, each of 
which may be made up of many cellular subtypes. In order to facilitate probing this 
hierarchical cell type structure, researchers often adopt an iterative analysis paradigm, 
wherein they first do broad cell type clustering (and marker gene analysis), and then 
break each broad cell type out into its own dataset before repeating this analysis 
process on each broad subtype independently. MiCV facilitates this type of analysis in 
two ways. Firstly, MiCV provides an annotation tab/webpage, wherein researchers can 
use automated cell type annotations, gene expression plots, pseudotime trajectories, 
gene expression trends, and gene information from external databases to select cells of
interest and extract them for analysis apart from the rest of the dataset. This is done 
non-destructively by adding user-provided annotations to the dataset and saving 
subsets of the data as independent copies that can be analyzed independently of one 
another. Secondly, MiCV provides a ‘summary report’ function that takes in an scRNA-
seq dataset and performs clustering and iterative subclustering analysis automatically 
for a user, ending with a printable PDF summary report that includes cell type UMAP 
plots, marker gene analysis, database information, and iterative subclustering results. A 
relatively novel feature in the space of user-facing scRNA-seq secondary analysis 
applications, these summary reports facilitate the rapid viewing and sharing of 
automatic secondary analysis, making it possible for multiple researchers with no 
programming experience to collectively analyze a dataset. Though not interactive, these
summary reports make it possible to rapidly inform the direction of iterative, interactive 
analysis steps by bringing more researchers and literature context together to tackle 
these complex datasets. 
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Fig. 3.20: Manually annotating cell types in MiCV
Integrating multiple bioinformatic analysis results, this page enables researchers to 
cross-filter cells by selecting them on any/all of the plots on this page, manually 
assigning cell types based on the researcher’s desired set of criteria (in a similar fashion
to cell gating in FACS software suites).
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Fig. 3.21: The MiCV summary report
In a completely automated fashion, MiCV takes in scRNA-seq datasets, performs the 
default scRNA-seq secondary analysis pipeline, generates publication ready plots with 
plain-language descriptors, and provides additional literature context to accelerate time 
to discovery. These shareable PDF reports facilitate the inclusion of many people when 
analyzing and forming hypotheses based around large and complex scRNA-seq 
datasets.
The future of single-cell experimental scope, design, and data analysis
In this chapter I have provided a brief outline of the steps involved in profiling mRNA 
expression at the single-cell level, walking through sample preparation, cell 
sorting/isolation, mRNA capture, sequencing, and both primary mapping as well as 
secondary counts matrix analysis. This outline, and the development of MiCV as a 
whole, was largely centered around needs and challenges I identified around the 
previously described scRNA-seq experiments we performed in order to profile the type 
II NB system in Drosophila. However it is generally appreciated that scRNA-seq, and 
more broadly the field of single-cell -omics (transcriptomics, proteomics, epigenomics, 
etc.) has been rapidly expanding since the development of droplet-based scRNA-seq 
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methodologies in 2015 (Aldridge and Teichmann, 2020; Macosko et al., 2015), and 
continues to do so to this day. This growth can largely be attributed to advances on the 
experimental design and secondary analysis frontiers, both of which I will outline here 
as future directions for my work in the type II NB system of Drosophila as well as for the 
single-cell secondary analysis tool I have developed.
A central feature of all scRNA-seq experimental protocols is the capture and barcoding 
with unique cellular barcodes of mRNA from individual cells. From a biochemical 
perspective, developing ssDNA oligos with cell barcodes and poly-dT regions that can 
bind the poly-A tails of mRNA makes this possible; however, there is no reason why this
capture need be limited to single-stranded oligos that contain long poly-A regions. As 
such, researchers have commandeered the use of droplet-based mRNA capture 
technologies to profile other aspects of cell status, including chromatin accessibility 
(scATAC-seq) (Buenrostro et al., 2015), DNA methylation (Mulqueen et al., 2018), and 
cell surface protein expression (Peterson et al., 2017) becoming both common and 
commercially supported. Additionally, work has been done to combine multiple assays 
into single reactions, enabling simultaneous readouts of both mRNA and surface protein
expression in the same cells (Peterson et al., 2017), for example. Integrating this 
information to link chromatin accessibility, mRNA, and protein expression can make it 
possible to address complex hypotheses, such as “What is the link between the 
accessibility of this region of the genome and mRNA expression of genes in that locus - 
and when mRNA is finally made, what protein expression changes can we observe in 
this specific cell type? Is this mRNA degraded before protein can be expressed? Is this 
protein long-lived relative to its mRNA?”. 
Furthermore, these same biochemistries have been translated from droplets to slides, 
enabling so-called ‘spatial sequencing’ assays (Asp et al., 2020; Cho et al., 2021; Liu et 
al., 2020; Rodriques et al., 2019). Typically performed by laying a fixed and 
permeabilized tissue slice atop a regular, micron-resolution grid of mRNA capture sites, 
these protocols generate not single-cell but single-micron resolution gene expression 
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data. In this way, specific regions of tissues can be profiled for thousands of genes in 
parallel, competing now with resources such as the Allen Brain Atlas (which profiles 
gene expression one gene at a time, compiling in situ hybridization results from the 
brains of thousands of animals) for utility (Lein et al., 2007). Alternative approaches to 
‘spatial sequencing’ imaging tissues prior to dissection/dissociation, aiming to identify 
cells of interest (typically those that express genetically-encoded fluorescent proteins) 
and ‘keep track’ of them during the mRNA capture process, as in (Nichterwitz et al., 
2016) and (Biase et al., 2018). Though currently throughput and sequencing quality 
limited, improvements to these techniques through the use of more robust multi-color 
barcoding and high-throughput imaging techniques such as bitbow (Li et al., 2020b; 
Veling et al., 2019) may yield promising results without the need for more costly tissue 
preps and spatial sequencing reagents. 
These new techniques make it possible to address new hypotheses in a high-
throughput, unbiased manner, but only when coupled with secondary analysis tools that
can accurately model and transform these new data types. Some work has been done 
to adopt previously developed scRNA-seq analysis tools to accept these new data 
formats, especially in the scATAC-seq (Butler et al., 2018; Danese et al., 2019) and 
single-cell surface protein sequencing (CITE/REAP-seq) (Lopez et al., 2018; Svensson 
et al., 2020) spaces where a ‘counts matrix’ akin to that in scRNA-seq data is still 
generated; here representing which genes are accessible and which surface proteins 
are detected, respectively. Spatial transcriptomic datasets, more visual in nature, are 
beginning to see the development of graphical user interfaces that enable interactive 
exploration of these datasets in a way akin to traditional fluorescence microscopy 
analysis (Palla et al., 2021). 
As these methods continue to develop, new computational approaches that improve 
analytical rigour, computational efficiency, and user accessibility will hopefully continue 
to develop alongside them. The strong dependency MiCV has on similar open source 
libraries will enable its continued development, making adding in support for these new 
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approaches trivial. It is my hope that by continuing to incorporate and provide intuitive 
interfaces for these new open source tools, MiCV will continue to accelerate our time to 
discovery in single-cell -omics projects as the field develops, further elucidating what 
makes each and every cell in the world unique. 
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Chapter 4
Conclusions and Future Directions
Summary of type-II neurogenesis work in Drosophila melanogaster
Drosophila melanogaster represents a model organism that recapitulates many features
of vertebrate neurogenesis. Unlike the abundant type-I neuroblasts (NB, neural stem 
cells), the 16 type II NBs in the Drosophila brain adopt a neurogenesis process that is 
directly analogous to that observed in mammalian cortical development (Homem and 
Knoblich, 2012). During development, each type II NB undergoes repeated asymmetric 
cell divisions to generate an NB and a sibling progeny that acquires a progenitor identity
(i.e. intermediate neural progenitor, INP). Each INP undergoes limited rounds of 
asymmetric cell division to re-generate and to produce a ganglion mother cell (GMC), 
which divides once more to become two neuron(s) and/or glial cell(s). Along this NB-
INP-GMC-neuron maturation process, cells express a well-defined cascade of 
transcription factors that mark these cell differentiation stages (Ren et al., 2017; Syed et
al., 2017). In parallel, INPs born in each division cycle may express a cascade of 
transcription factors unique to each NB lineage that contribute to the generation of 
different neural progenies (Bayraktar and Doe, 2013). It is highly plausible that the 
combination of these two transcription factor cascades alongside a third molecular axis, 
which defines unique NBs (i.e., each NB generates a distinct lineage), brings about the 
generation of a highly diverse neuronal pool.
In chapter 1, I described the current state of the field surrounding type-II neurogenesis 
in Drosophila. In particular, I laid out how temporally varying transcription factor 
cascades modulate the neurogenic potential of type-II NBs and INPs, and discuss low-
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throughput antibody/functional manipulation studies have previously been used to 
characterize these changes during neural development. Despite the massive 
significance of these studies, their reliance on antibody libraries limits their scope. 
Drosophila melanogaster has a genome with more than 14,000 protein-coding genes, at
least 700 of which exhibit transcription factor activities (Shokri et al., 2019). Though 
direct-screening techniques are powerful, the advent of high throughput single-cell 
mRNA sequencing (scRNA-seq) technologies has enabled researchers to much more 
broadly investigate the mRNA expression landscape of hundreds of thousands of cells 
(Macosko et al., 2015; Ziegenhain et al., 2017). Coupled with a vast array of analytical 
tools that enable us to take these high-dimensional datasets and identify significant 
molecular signatures from them (Butler et al., 2018; Wolf et al., 2018), researchers can 
make hypotheses about the number of unique cellular subtypes in the brain 
(Cocanougher et al., 2019; Saunders et al., 2018), what the functions of these subtypes 
might be (Ren et al., 2019), and what subtypes might arise together along a common 
developmental pathway (Cao et al., 2019; Qiu et al., 2017; Soldatov et al., 2019). This 
combination of experimental and analytical advances has removed the need to rely 
solely on limited and biased single-molecule screens, instead enabling experiments to 
yield information about the near-complete mRNA expression landscape of thousands of 
cells at a time without the need for prior knowledge about/reagents for probing specific 
genes of interest. 
In chapter 2, I described how we used targeted single cell transcriptome analysis to 
advance our understanding of the Drosophila type-II neuron differentiation process. 
After initially separating the transcriptomes of the type-II neuroblast derived cells from 
those labeled in the optic lobes, we show that pseudotime analysis techniques can be 
used to define a maturation axis and extract putative marker genes that specify the INP,
GMC, immature neuron and mature neuron differentiation stages. Broadly expressed, 
not limited to the type-II NB progenies, these marker genes of different maturation 
stages indeed form intersectional patterns that represent the spatial organization of the 
neurogenesis progress in the larval brain. Compared to previous antibody-based and 
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gene manipulation-based screening strategies, scRNA-seq data permits a high-
throughput assessment of the whole gene expression profile to rapidly identify 
candidate genes for functional study. For instance, in the past, Hey has been shown to 
mark one of the two immature neurons derived from the final cell division, and its role is 
exclusive as an inhibitor of Notch signaling in this immature neuron (Monastirioti et al., 
2010). From our scRNAseq analysis, E(spl)m6-BFM, a member of the enhancer-of-split 
family of transcription factors (Lai et al., 2000), and Rbp, a rim-binding protein 
responsible for synaptic homeostasis and neurotransmitter release (Liu et al., 2011; 
Müller et al., 2015) are exclusively up-regulated in only the transient immature neuronal 
differentiation state directly after GMC division. These two marker genes can be used to
guide the exploration of Hey- immature neurons in future studies. Functional knock-outs
of these two genes will be critical to understanding their function in newly-born neurons 
as it pertains to their maturation and any early functional role they may play in the 
developing brain.
Further higher-resolution clustering of the INP and GMC cells identified 
transcriptomically correlated subclusters between these two stages, which supports the 
idea that parallel maturation transitions happen at the same developmental time point. 
However, scRNA-seq data alone cannot distinguish whether these parallel transitions 
are due to the co-existence of earlier and newly born INPs in all NB lineages or due to 
the intrinsic differences among NB lineages. We therefore in situ profiled the marker 
genes selected from the scRNA-seq selected candidates and restored their missing 
spatial information that indicates the maturation stage as well as the NB lineage identity.
In addition, combined with prior knowledge, whether a marker gene is expressed in 
younger or earlier born INPs can also be speculated. Our findings conclude that Sp1 is 
expressed in the young INPs of nearly all NB lineages, whereas TfAP-2 and Fas3 
express in older INPs belonging to specific NB lineages. Interestingly, we found that 
Sp1 and TfAP-2 expressed not only in neural progenitors but also in maturing neurons. 
These transcription factors seem to intermingle with the NB lineage-specific D/grh/ey 
cascades in the INP stage, but eventually differentiate into completely exclusive neuron 
101
populations. Finally, higher-resolution clustering of neurons in our scRNAseq dataset 
revealed that transcription factors and surface molecules are predominant markers for 
distinct neuronal subtypes at the 3rd instar larval stage. This implies that most neurons 
of the type-II NB progenies have not started to gain their differentiated functions at this 
stage of development.
Combining in silico scRNA-seq analysis and in situ mRNA imaging, we discovered 
many transcription factors and surface molecules that potentially play important roles in 
generating neuronal subtypes in an NB-specific, INP-specific, or function-specific 
manner. These discoveries helped us to gain a comprehensive understanding of the 
molecular landscape along all three major neural developmental axes that define a 
cell’s progenitor lineage identity, progenitor cell division number, and differentiation 
state (Fig. 2.14). This model provides a general guidance for biologists to disentangle 
the differentiation process in complex systems beyond the Drosophila brain.
Though the scope of our work here may have been considered unprecedented 6 years 
ago (scope here referring to how we sequenced approximately 4000 cells that were 
neurons originating from 16 Drosophila type-II neuroblast lineages), many open 
questions still remain. With low-resolution clustering, we identified 13 molecularly 
distinct neural subtypes. Increasing the clustering resolution just a bit higher we could 
identify more than 20 that are still distinct (data not shown). Similarly, as we show with 
the INPs/GMCs in our dataset, a low-resolution clustering can often mask the cellular 
diversity that is present in the system. As we know that each type-II neuroblast 
generates approximately 38 INPs throughout their developmental lifespan (Bayraktar et 
al., 2010; Bello et al., 2008), the presented clustering in this paper only captures part of 
the INP diversity. One straightforward thought is to increase the number of sequenced 
single cells so that higher clustering resolution may eventually reveal even the most 
subtle differences between each of the hundreds of INPs in the type-II system. 
However, as transcription factor cascades involved in INP division/maturation intertwine 
with those involved in NB specification and differentiation, we expect that the INP 
heterogeneity can be untangled somewhat using a higher clustering resolution but still 
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fails to provide us with a coherent view of the complex lineage, maturation, and 
differentiation landscape we are attempting to characterize. These issues highlight the 
challenge of deconvoluting the INP maturation, NB lineage, and differentiation state 
axes and the need for a holistic, integrated approach to experimental design and 
subsequent bioinformatic analysis.
The data we have presented here were collected at a single developmental time-point 
(late third instar), but we know that type-II neurogenesis precedes and continues after 
this stage. Repeating these scRNA-seq experiments at more developmental time-points
will reveal more in what order molecularly-defined neural subsets are generated. Using 
recently developed analytical techniques to “stitch” these multi-time-point datasets 
together (Lin et al., 2019; Tran and Bader, 2019) will be advantageous to align all the 
cells along a unified developmental time axis. To overcome the limitation of the R9D11-
Gal4 driver, which does not label neuroblasts nor the fully mature neurons, a permanent
labeling strategy, similar to the one used in (Bayraktar et al., 2010) but covering all 
lineages more reliably for FACS, is required. More critically, such permanent labeling 
needs to be paired with technologies that provide single-lineage specification resolution,
such as the introduction of single-neuroblast lineage barcoding techniques. Genetic 
constructs based around CRISPR-Cas9 (Raj et al., 2017; Spanjaard et al., 2018) and 
the Cre/Lox system (Kalhor et al., 2018; Pei et al., 2017; Weber et al., 2016) have been 
developed for this purpose, although which exact lineage was labeled by a particular 
barcode was still unknown. The introduction of a spectrally unique barcode for each 
neuroblast lineage, in a similar vein to the recently developed Bitbow lineage tracking 
strategy (Li et al., 2020; Veling et al., 2019), would be advantageous as they can 
provide direct in situ evidence for neuroblast lineage identity.
Finally, our work identifies several transcription factors that are specifically expressed in
subsets of cells of the type-II neuroblast progenies. Our in silico and in situ results 
showed that their expressions are either constrained to particular developmental stages,
or in subsets of cells that are born in different orders. It would be desired to perform 
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follow up experiments to reveal whether these transcription factors play important roles 
in specifying the terminal fates of type-II neuronal subtypes.
The future of single-cell experimental scope, design, and data analysis
In chapter 3 I have provided a brief outline of the steps involved in profiling mRNA 
expression at the single-cell level, walking through sample preparation, cell 
sorting/isolation, mRNA capture, sequencing, and both primary mapping as well as 
secondary counts matrix analysis. This outline, and the development of MiCV as a 
whole, was largely centered around needs and challenges I identified around the 
previously described scRNA-seq experiments we performed in order to profile the type 
II NB system in Drosophila. However it is generally appreciated that scRNA-seq, and 
more broadly the field of single-cell -omics (transcriptomics, proteomics, epigenomics, 
etc.) has been rapidly expanding since the development of droplet-based scRNA-seq 
methodologies in 2015 (Aldridge and Teichmann, 2020; Macosko et al., 2015), and 
continues to do so to this day. This growth can largely be attributed to advances on the 
experimental design and secondary analysis frontiers, both of which I will outline here 
as future directions for my work in the type II NB system of Drosophila as well as for the 
single-cell secondary analysis tool I have developed.
A central feature of all scRNA-seq experimental protocols is the capture and barcoding 
with unique cellular barcodes of mRNA from individual cells. From a biochemical 
perspective, developing ssDNA oligos with cell barcodes and poly-dT regions that can 
bind the poly-A tails of mRNA makes this possible; however, there is no reason why this
capture need be limited to single-stranded oligos that contain long poly-A regions. As 
such, researchers have commandeered the use of droplet-based mRNA capture 
technologies to profile other aspects of cell status, including chromatin accessibility 
(scATAC-seq) (Buenrostro et al., 2015), DNA methylation (Mulqueen et al., 2018), and 
cell surface protein expression (Peterson et al., 2017) becoming both common and 
commercially supported. Additionally, work has been done to combine multiple assays 
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into single reactions, enabling simultaneous readouts of both mRNA and surface protein
expression in the same cells (Peterson et al., 2017), for example. Integrating this 
information to link chromatin accessibility, mRNA, and protein expression can make it 
possible to address complex hypotheses, such as “What is the link between the 
accessibility of this region of the genome and mRNA expression of genes in that locus - 
and when mRNA is finally made, what protein expression changes can we observe in 
this specific cell type? Is this mRNA degraded before protein can be expressed? Is this 
protein long-lived relative to its mRNA?”. 
Furthermore, these same biochemistries have been translated from droplets to slides, 
enabling so-called ‘spatial sequencing’ assays (Asp et al., 2020; Cho et al., 2021; Liu et 
al., 2020; Rodriques et al., 2019). Typically performed by laying a fixed and 
permeabilized tissue slice atop a regular, micron-resolution grid of mRNA capture sites, 
these protocols generate not single-cell but single-micron resolution gene expression 
data. In this way, specific regions of tissues can be profiled for thousands of genes in 
parallel, competing now with resources such as the Allen Brain Atlas (which profiles 
gene expression one gene at a time, compiling in situ hybridization results from the 
brains of thousands of animals) for utility (Lein et al., 2007). Alternative approaches to 
‘spatial sequencing’ imaging tissues prior to dissection/dissociation, aiming to identify 
cells of interest (typically those that express genetically-encoded fluorescent proteins) 
and ‘keep track’ of them during the mRNA capture process, as in (Nichterwitz et al., 
2016) and (Biase et al., 2018). Though currently throughput and sequencing quality 
limited, improvements to these techniques through the use of more robust multi-color 
barcoding and high-throughput imaging techniques such as bitbow (Li et al., 2020b; 
Veling et al., 2019) may yield promising results without the need for more costly tissue 
preps and spatial sequencing reagents. 
These new techniques make it possible to address new hypotheses in a high-
throughput, unbiased manner, but only when coupled with secondary analysis tools that
can accurately model and transform these new data types. Some work has been done 
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to adopt previously developed scRNA-seq analysis tools to accept these new data 
formats, especially in the scATAC-seq (Butler et al., 2018; Danese et al., 2019) and 
single-cell surface protein sequencing (CITE/REAP-seq) (Lopez et al., 2018; Svensson 
et al., 2020) spaces where a ‘counts matrix’ akin to that in scRNA-seq data is still 
generated; here representing which genes are accessible and which surface proteins 
are detected, respectively. Spatial transcriptomic datasets, more visual in nature, are 
beginning to see the development of graphical user interfaces that enable interactive 
exploration of these datasets in a way akin to traditional fluorescence microscopy 
analysis (Palla et al., 2021). 
As these methods continue to develop, new computational approaches that improve 
analytical rigour, computational efficiency, and user accessibility will hopefully continue 
to develop alongside them. The strong dependency MiCV has on similar open source 
libraries will enable its continued development, making adding in support for these new 
approaches trivial. It is my hope that by continuing to incorporate and provide intuitive 
interfaces for these new open source tools, MiCV will continue to accelerate our time to 
discovery in single-cell -omics projects as the field develops, further elucidating what 
makes each and every cell in the world unique. 
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A1: How Complex is Neural Fate Patterning? Theoretical Limits on Neural 
Diversity
In chapter 1 I described current literature around neural fate patterning mechanisms, 
with the following major mechanisms playing a role in defining neural fate:
A. Neural stem cell lineage identity 
B. Neural stem cell age/division number (global developmental time)
C. Intermediate neural progenitor age/cell division number
D. Notch on/off state (when a precursor cell divides, one daughter cell is typically 
Notch on, the other Notch off)
E. Spatial targeting cues that direct neurons to make synaptic connections with 
specific neurons (can have retrograde effect on neural identity)
By assuming each of these mechanisms is discrete in nature and subsequently 
estimating the number of unique states each of these mechanisms can be in, we can 
begin to put limits on the number of neural fates possibly generated using these 
mechanisms. This assumption fails for facet E (the effect of spatial targeting cues), 
which is a more continuous, complex, and often subtle patterning mechanism, and so 
we will ignore it here. 
Given the number of identifiable discrete states for each of the four remaining 
mechanisms, we can estimate the maximal number of unique neural fates as:
N=a ⋅b ⋅c ⋅ d (eq. A1.1)
where a is the number of discrete states for mechanism A (lineage identity), b the 
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number of for mechanism B (neural stem cell age), and likewise for c and d. 
Based on previous work in the type II neuroblast system in Drosophila, and assuming 
we are interested in characterizing the number of unique neural fates up to the late 3rd 
instar larval stage (the context of this thesis), is is possible to estimate values for each 
of the variables in this equation:
A. There are 16 type II neuroblasts (8 per brain lobe), therefore a=16
B. It is not known precisely how many times each type II NB divides, therefore on 
the surface b is unknown. However, given that at the late L3 stage there are 
approximately 160 INPs total (80 INPs per brain lobe (Bayraktar et. al., 2010)) we
can assume that each NB divides 10 times by late L3, and therefore b=10
C. Each INP divides between 4-8 times (an average of 6), therefore c=6. Knowing 
the median number of INP divisions would enable a better estimate for c.
D. Each precursor (GMC) divides once to generate one Notch on and one Notch off 
daughter cell, therefore d=2
Our estimate of the maximum number of unique neural fates then becomes:
N=¿a ⋅b ⋅ c ⋅d  = (16)⋅(10)⋅(6) ⋅(2)=1920 (eq. A1.2)
which is in line with our total type II progeny cell count in the late L3 brain, based on 
images from the R9D11-Gal4 fly driver line crossed to our UAS-hH2b::2xmNG line 
(chapter 2). And indeed, we should expect the upper limit on the number of unique 
neural fates to be equal to the total number of neurons generated by the combination of 
these mechanisms - with these progenitor patterning-based fate specification 
mechanisms, we cannot have more neural fates than neurons to assign them to!
 
However, Eq. A1.2 represents a maxima that is potentially far greater than the true 
number of achievable neural fates. For it to be an accurate estimate of the true number 
of unique fates, a second assumption must be made about the independence of each of
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these 4 mechanisms - namely, that they are completely independent of one another. 
This assumption likely does not hold, though the severity of the interdependence of 
these four mechanisms is challenging to estimate. 
In Chapter 2, I determined experimentally that there are 13 obviously identifiable neural 
subtypes in the type II system at the late L3 stage of larval development - 20 subtypes, 
if we increase scRNA-seq clustering resolution. Since clustering resolution can be 
somewhat arbitrary, let us take 20 as our ‘experimentally determined’ number of unique 
neural fates - defined at least at the mRNA expression level. It is therefore apparent 
that:
N (maximum)≫N (observed)(eq. A1.3)
since N(maximum)=1920 and N(observed)=20, a difference of more than 2 orders of 
magnitude. While we expect our number of observed neural fates to be smaller than our
estimated maximum, the scale of this difference warrants a refinement of our 
assumptions about each mechanism. 
An important feature of brain development observed in almost all organisms with central
nervous systems is lateral symmetry (brain lateralization), wherein across the two semi-
independent lateral brain lobes there is obvious symmetry of gross anatomical features 
(Duboc et al. 2015). Though these two brain lobes are not completely identical, it stands
to reason that in the relatively simple Drosophila developing CNS we can assume that 
the 16 type II NBs are laterally symmetric, with 8 in each lobe. Therefore:
a=8→N (maximum)=960 (eq. A1.4)
We can continue to refine our estimate for a by incorporating what we learned from our 
in situ and scRNA-seq data related to INP subtypes; specifically, that the INPs from 
DM1, 2, and 3 all appear to express Fas3, and that INPs from DM4, 5, and 6 all appear 
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to express TfAP-2. Though these lineages are likely not completely identical (and 
indeed, previous work shows they are not (Bayraktar and Doe 2013), it stands to reason
that there may be some redundancy among lineages DM1-3 and DM4-6, respectively. If
we make the gross over-assumption than DM1-3 are replicated lineage, and likewise 
with DM4-6, then we have:
a=4→N (maximum)=480 (eq. A1.5)
Additionally, we can refine our estimate for c, the number of neural fates we can 
attribute to INP patterning transitions. Initially we estimated this as the average number 
of times an INP divides (c=6), however the exemplary work by Bayraktar and Doe 
describing INP combinatorial patterning points in general towards each INP transitioning
to express 3 unique transcription factors, with variability across NB lineages in the way 
these transcription factors co-express to define a unique patterning state (Bayraktar and
Doe 2013). At the very least, they identify 4 uniquely identifiable neural fates arising 
from the DM 2-3 NB lineages. As such, we could arrive at:
c=4→N (maximum)=320 (eq. A1.6)
The inclusion of additional mechanisms (for example E, the connectomic/retrograde 
signalling neural fate patterning mechanism) would only increase our estimate further. 
Taken together then, we might conclude that while this combinatorial patterning system 
makes theoretically possible more than 2000 unique neural fates, only approximately 1-
5% of that potential ‘fate-space’ appears to actually be utilized by the late L3 stage of 
brain development in Drosophila. 
Critically, this conclusion is dependent on a number of assumptions, chief among them 
that the 20 neural subtypes identified in scRNA-seq analysis are truly the only unique 
neural fates attainable by type II progeny at this stage. This number is likely an 
underestimate of the true neural diversity, due to the fact that scRNA-seq experiments 
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are currently only capable of sampling 1-10% of the total mRNA in a given mammalian 
cell (Shapiro et al. 2013), and that it is statistically unlikely that each unique neural fate 
is represented by a cell in our dataset (i.e. we ‘missed’ some cells in the single-cell 
sequencing process), though that we have sampled the vast majority of them is likely 
the case. Technological improvements in mRNA capture techniques, as well as 
improvements to genetic labelling and cell sorting techniques, will improve our 
resolution and neural subtype sampling completeness. Taken together, such 
improvements would be likely to increase the number of neural subtypes we would 
identify at any given developmental stage, should these experiments be repeated in the 
Be that as it may, these estimates combined with our scRNA-seq and in situ data point 
towards the conclusion that the type II system’s ‘goal’, and thus the ‘goal’ of 
neurogenesis via intermediate neural progenitors in Drosophila, is not solely to 
maximize neural diversity. It is possible that robustness and redundancy in neural fate 
determination (i.e. ensuring that each fate is represented in the proper ratios despite 
potential cell death/failure to differentiate/etc.) is an additional benefit to using 
neurogenesis via intermediate progenitors. In conclusion, both neural diversity and 
robustness of neural pool generation may simultaneously be advanced by utilizing this 
mechanism, and further studies across this and other organisms may further refine the 
balance between these two benefits and show why neurogenesis via intermediate 
progenitors eventually became the predominant neurogenesis mechanism is higher 
vertebrates. future.
Be that as it may, these estimates combined with our scRNA-seq and in situ data point 
towards the conclusion that the type II system’s ‘goal’, and thus the ‘goal’ of 
neurogenesis via intermediate neural progenitors in Drosophila, is not solely to 
maximize neural diversity. It is possible that robustness and redundancy in neural fate 
determination (i.e. ensuring that each fate is represented in the proper ratios despite 
potential cell death/failure to differentiate/etc.) is an additional benefit to using 
neurogenesis via intermediate progenitors. In conclusion, both neural diversity and 
robustness of neural pool generation may simultaneously be advanced by utilizing this 
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mechanism, and further studies across this and other organisms may further refine the 
balance between these two benefits and show why neurogenesis via intermediate 
progenitors eventually became the predominant mechanism in vertebrates. 
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A2: Reagents Used in Experimental Characterization of Type-II NB System
Table 2.2: Reagents categorized by type
Reagent SOURCE IDENTIFIER
Antibodies
Mouse monoclonal anti-Fas3 DHSB Cat# 7G10, RRID:AB_528238
Rat monoclonal anti-Dpn
Lee, C.Y., 
Robinson, K.J., and 









Laboratories, Inc. Cat# 712-605-150
Chemicals, Peptides, and Recombinant Proteins
Papain Millipore Sigma Cat# P4762-25MG
Collagenase type I Millipore Sigma Cat# SCR103
E-64 Millipore Sigma Cat# E3132-1MG
Fetal Bovine Serum Millipore Sigma Cat# F0926-50ML
Schneider’s Media Millipore Sigma Cat# S0146-500ML
DRAQ5 abcam Cat# ab108410
Dextran sulfate, 50% solution Millipore Sigma Cat# S4031
Critical Commercial Assays
10X chromium v3 single-cell 
gene expression kit 10X Genomics Cat# 1000154
10X chromium v2 single-cell 
gene expression kit 10X Genomics Cat# 120234
Deposited Data
Raw reads and analyzed 















hH2B::2xmNG This study NA
D. melanogaster: yw;;UAS-
hH2B::2xTagBFP2 This study NA
D. melanogaster, Sp1::EGFP










mNeonGreen HCR probe set
Molecular 
Instruments PRC014
CycE HCR probe set
Molecular 
Instruments PRD167
D HCR probe set
Molecular 
Instruments PRC881
Sp1 HCR probe set
Molecular 
Instruments PRC883
TfAP-2 HCR probe set
Molecular 
Instruments PRD168
Fas3 HCR probe set
Molecular 
Instruments PRC900
ytr HCR probe set Molecular PRE680
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Instruments




tap HCR probe set
Molecular 
Instruments PRE682
jim HCR probe set
Molecular 
Instruments PRE686




dati HCR probe set
Molecular 
Instruments PRG385
mamo HCR probe set
Molecular 
Instruments PRG383









scanpy scRNA-seq analysis 
software
Wolf, F., Angerer, 
P. & Theis, F., 2018 RRID:SCR_018139




trajectory fitting software 
Setty, M., 
Kiseliovas, V., 
Levine, J. et al., 
2019 https://github.com/dpeerlab/Palantir
PyGAM model fitting 
software
Servén D, Brummitt 
C, Abedi H, 2018 https://github.com/dswah/pyGAM





A3: Single-Cell Dissociation Protocol for Larval Drosophila Brains
Materials
On ice:
 20mg/mL papain (solution in water)
 20mg/mL collagenase
 100X E-64 protease inhibitor
 1X Rinaldini’s solution
 Schneider’s insect culture media + 10% FBS
 DRAQ5 or other DNA/live/dead-cell stain(s)
At room temperature:
 15uM ZnCl solution (alternatively, 100mM CaCl2 solution: both are 100X working
concentration for chemical digestion)
Other:
 DNA low-binding 1.5mL tubes 
 Silicanized p200 pipette tips (green, brains stick less to them)
 Heat block set to 37C
 96-well plate, non-sterile is fine (for visualizing cells post-sort)
Notes
 Keep tubes with brains on ice unless otherwise noted
Dissection
1. Prepare a 1.5mL DNA low-binding tube with 30uL 1X Rinaldini’s solution
2. Dissect larval brains in cold 1X Rinaldini’s solution
3. Transfer brains to 1.5mL tube from step (1)
4. Dissect for no more than 1hr total to avoid early-dissected brains from 
deteriorating too much relative to late-dissected brains
119
Chemical digestion
1. Bring the volume of the tube with dissected brains up to 80uL with 1X Rinaldini’s 
solution (either wash and replace, or add on top of media in tube, depending on 
how clean your dissections are/careful you’d like to be)
2. Add 10uL of 20mg/mL papain (final conc. 2mg/mL)
3. Add 10uL of 20mg/mL collagenase (final conc. 2mg/mL)
4. Add 1uL of 15uM ZnCl solution (final conc. 150nM; Zn or Ca ions necessary for 
optimal collagenase activity, according to spec sheets) 
5. Mix gently by flicking the tube, until you see collagenase mix uniformly and/or 
brains from bottom of tube come up into the solution
6. Incubate at 37C for 60min on the heat block
◦ At 15min intervals, mix gently by taking the tube off of the heat block and 
flicking, as in step (5). 
7. After incubation, place tube on ice and add 1uL E-64 100X solution; mix gently 
by flicking – E-64 binds papain irreversibly, quenching the digestion reaction
8. Incubate on ice for 2min
9. Spin brains down at 500G for 3min
10. Remove most of the solution using silicanized p200 tip
11. Re-suspend brains by adding Schneider’s + 10% FBS solution to approximately 
100uL final volume
Mechanical disruption
1. Set the volume of a p100 pipettor to 70% (approximately 70% of the total volume;
adjust if using a higher volume)
2. Attach a silicanized p200 (green) pipette tip
3. Open tube, and hold up to a bright working lamp to clearly visualize brains. 
4. Insert pipette tip and hold just above the bottom of the tube (about 1mm)
5. Pipette up and down in a smooth rhythm 30 times, at a rate of about 1.5 full 
pipetting motions every second
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◦ Try not to be overly forceful but instead aim to maintain a consistent forward 
and back-pressure
◦ We have found this area of the protocol can be critical to dissociation 
success, particularly for larval VNCs where the cells seem to be more tightly 
coupled together – practice practice practice!
Sorting
1. Estimate cell concentration using a hemocytometer
2. Dilute dissociated cells in more Schneider’s + 10% FBS to approach a desired 
cell concentration
◦ For most commercial FACS systems, aim for at least 500uL to avoid cell loss 
due to ‘dead volume’ (volume of solution at the bottom of the tube that the 
FACS sample injection system cannot physically reach)
3. Transfer cells to a FACS tube appropriate for your FACS machine 
4. Add cell stain(s) to appropriate tubes
◦ if DRAQ5 (recommended), add 1uL of DRAQ5 stock to 500uL of dissociated 
cells, and do not wash afterwards
5. Sort into 1.5mL tubes pre-filled with at least 200uL of Schneider’s + 10% FBS, or 
other capture media/vessels
6. Spin down cells after sorting at 300G for 5 min
7. Remove excess media and re-suspend at desired cell concentration
◦ Assume “true” cell count in tube is ~70% of what the FACS machine reports 
were sorted into the tube
8. Estimate cell concentration by taking 5uL of cells and transferring to a single well 
of a 96-well plate, pre-loaded with 25uL of media, spinning down at 400G for 2 
min, and counting FP+ cells on an epifluorescent scope
◦ Hemocytometer is not reliable at low cell concentration, and may require 
more cells than you have. If you want, you can skip this step and proceed 
straight to 10X/other scRNA-seq prep platform, but the technician’s might not 
like it!
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A4: HCRv3 Staining Protocol for Larval Drosophila Brains
Tissue fixation and preparation
● Fix brains in 4% PFA for 20min @ RT, nutating
● Wash and permeablize brains in 0.3% PBSTw
○ 2x for 30s @ RT, standing
○ 1x for 20min @ RT, nutating
○ 1x again @ RT, nutating OR standing @ 4C ← stopping point
HCR probe hybridization
● Incubate brains in 500uL hybridization buffer (see below) @ 37C for 60min, 
nutating
● Add 2.5uL of 1uM probe stock for each probe (5nM final concentration)
● Incubate @ 37C overnight, nutating
● Wash 2x in wash buffer (see below) @ RT for 30min, nutating
HCR imager amplification
● Incubate brains in 500uL amplification buffer (see below) @ RT for 30min, 
nutating
● Snap-cool imager hairpins:
○ Each HCR probe has 2 imager hairpins that go along with it, labeled 
B(n)H(1/2)
○ Add 10uL of each imager hairpin stock solution (3uM) to separate PCR 
tubes
○ Incubate imager hairpins @ 95C for 90s, then cool to RT/4C immediately
● Add 10uL of each imager hairpin to brains (60nM final concentration for each 
hairpin)
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● Incubate @ RT overnight, nutating
● Wash 2x with 2XSSCTw @ RT for 30min, nutating
● Wash 1x with 2XSSC @ RT indefinitely, nutating ← stopping point
Table 2.3: HCR Buffer recipes
0.3% PBSTw (approximate)
50% Tween 20 1 drop (~50uL) 
1X PBS 8283uL
2X SSCTw (0.5% Tween 20, approximate)




50% dextran sulfate 200uL
20X SSC 100uL











50% dextran sulfate 200uL





A5: Open Source Software Packages Used in This Work
Alex Wolf, Philipp Angerer, Fidel Ramirez, Isaac Virshup, Sergei Rybakov, Gokcen 
Eraslan, Tom White, Malte Luecken, Davide Cittaro, Tobias Callies, Marius Lange, 
Andrés R. Muñoz-Rojas. (2021, February 24). scanpy. Retrieved May 18, 2021, from 
http://github.com/theislab/scanpy (Original work published July 24, 2017)
Ali-Akber Saifee. (2020, August 25). flask-limiter. Retrieved May 18, 2021, from 
https://flask-limiter.readthedocs.org (Original work published February 12, 2014)
  
Alistair Miles. (2021, January 26). numcodecs. Retrieved May 18, 2021, from 
https://github.com/zarr-developers/numcodecs (Original work published September 19, 
2016)
  
Alistair Miles. (2021, April 16). zarr. Retrieved May 18, 2021, from 
https://github.com/zarr-developers/zarr-python (Original work published December 18, 
2015)
Anaconda, Inc. (2020, June 30). numba. Retrieved May 18, 2021, from 
http://numba.github.com (Original work published August 15, 2012)
  
Andy McCurdy. (2020, June 1). redis. Retrieved May 18, 2021, from 
https://github.com/andymccurdy/redis-py (Original work published October 8, 2012)
  
Armin Ronacher. (2020, April 3). flask. Retrieved May 18, 2021, from 
https://palletsprojects.com/p/flask/ (Original work published April 16, 2010)
  
Armin Ronacher. (2021, March 18). flask-sqlalchemy. Retrieved May 18, 2021, from 
https://github.com/pallets/flask-sqlalchemy (Original work published June 2, 2010)
  
Ask Solem. (2020, December 16). celery. Retrieved May 18, 2021, from 
http://celeryproject.org (Original work published April 27, 2009)
  
Benedikt Schmitt. (2019, May 18). filelock. Retrieved May 18, 2021, from 
124
https://github.com/benediktschmitt/py-filelock (Original work published July 6, 2014)
  
Benoit Chesneau. (2021, April 27). gunicorn. Retrieved May 18, 2021, from 
https://gunicorn.org (Original work published January 3, 2010)
Chris Parmer. (2021, April 8). dash. Retrieved May 18, 2021, from 
https://plotly.com/dash (Original work published June 20, 2017)
Cloudpipe. (2020, August 25). cloudpickle. Retrieved May 18, 2021, from 
https://github.com/cloudpipe/cloudpickle (Original work published April 16, 2015)
  
Daniel Serven. (2018, October 31). pygam. Retrieved May 18, 2021, from 
https://github.com/dswah/pyGAM (Original work published May 10, 2017)
  
Denis Bilenko. (2021, January 20). gevent. Retrieved May 18, 2021, from 
http://www.gevent.org/ (Original work published July 20, 2009)
  
Elmer Thomas, Yamil Asusta. (2021, April 21). sendgrid. Retrieved May 18, 2021, from 
https://github.com/sendgrid/sendgrid-python/ (Original work published June 28, 2012)
  
Faculty. (2021, March 21). dash-bootstrap-components. Retrieved May 18, 2021, from 
https://dash-bootstrap-components.opensource.faculty.ai/ (Original work published 
September 21, 2018)
  
Flask-Admin team. (2021, April 17). flask-admin. Retrieved May 18, 2021, from 
https://github.com/flask-admin/flask-admin/ (Original work published July 11, 2011)
  
Francesc Alted, Valentin Haenel. (2020, September 9). blosc. Retrieved May 18, 2021, 
from http://github.com/blosc/python-blosc (Original work published November 17, 2010)
  
Golovanov Stanislav. (2017, January 9). pdfkit. Retrieved May 18, 2021, from 
UNKNOWN (Original work published January 8, 2013)
  
Grey Li. (2021, May 18). bootstrap-flask. Retrieved May 18, 2021, from 
https://github.com/greyli/bootstrap-flask (Original work published June 11, 2018)
  
Inada Naoki. (2020, December 18). msgpack. Retrieved May 18, 2021, from 
https://msgpack.org/ (Original work published January 6, 2018)
Inkscape Project. (2020). Inkscape. Retrieved from https://inkscape.org
125
Jean-Christophe Fillion-Robin. (2020, November 11). cmake. Retrieved May 18, 2021, 
from http://cmake.org/ (Original work published November 9, 2016)
  
Jonathan Underwood. (2020, November 18). lz4. Retrieved May 18, 2021, from 
https://github.com/python-lz4/python-lz4 (Original work published January 31, 2012)
  
Joshua Tauberer. (2020, November 5). email_validator. Retrieved May 18, 2021, from 
https://github.com/JoshData/python-email-validator (Original work published April 21, 
2015)
Kluyver, T., Ragan-Kelley, B., Pérez, F., Granger, B., Bussonnier, M., Frederic, J., … 
Willing, C. (2016). Jupyter Notebooks – a publishing format for reproducible 
computational workflows. In F. Loizides & B. Schmidt (Eds.), Positioning and Power in 
Academic Publishing: Players, Agents and Agendas (pp. 87–90).
Konsta Vesterinen. (2020, June 2). wtforms_alchemy. Retrieved May 18, 2021, from 
https://github.com/kvesteri/wtforms-alchemy (Original work published January 26, 2013)
  
Krzysztof Polanski, Jongeun Park. (2020, June 9). bbknn. Retrieved May 18, 2021, from
https://github.com/Teichlab/bbknn (Original work published July 19, 2018)
  
Leland McInnes. (2020, May 15). umap-learn. Retrieved May 18, 2021, from 
http://github.com/lmcinnes/umap (Original work published November 10, 2017)
  
Leonard Richardson. (2020, October 3). beautifulsoup4. Retrieved May 18, 2021, from 
http://www.crummy.com/software/BeautifulSoup/bs4/ (Original work published October 
2, 2013)
  
magic-impute. (2019, November 18). Retrieved May 18, 2021, from 
https://github.com/KrishnaswamyLab/MAGIC (Original work published July 24, 2018)
  
Manu Setty. (2020, May 20). palantir. Retrieved May 18, 2021, from 
https://github.com/dpeerlab/palantir (Original work published March 6, 2020)
  
Matt Wright & Chris Wagner. (2020, July 28). flask-security-too. Retrieved May 18, 
2021, from https://github.com/Flask-Middleware/flask-security (Original work published 
April 25, 2019)
  
Niko Pasanen <niko@pasanen.me>. (2020, October 27). dash-uploader. Retrieved May
126
18, 2021, from https://github.com/np-8/dash-uploader (Original work published April 26, 
2020)
  
Patrick Vogel, Bogdan Petre. (2020, September 9). flask_monitoringdashboard. 
Retrieved May 18, 2021, from https://github.com/flask-dashboard/Flask-
MonitoringDashboard (Original work published February 27, 2018)
Peter Justin. (2020, June 2). flask_caching. Retrieved May 18, 2021, from 
https://github.com/sh4nks/flask-caching (Original work published July 4, 2016)
  
Philipp Angerer, Alex Wolf, Isaac Virshup, Sergei Rybakov. (2021, April 11). anndata. 
Retrieved May 18, 2021, from http://github.com/theislab/anndata (Original work 
published November 7, 2017)
  
plotly. (2018, December 19). dash-dangerously-set-inner-html. Retrieved May 18, 2021,
from https://pypi.org/project/dash-dangerously-set-inner-html/ (Original work published 
December 7, 2017)
  
Seth M. Morton. (2020, November 21). natsort. Retrieved May 18, 2021, from 
https://github.com/SethMMorton/natsort (Original work published November 17, 2012)
  
Stochastic Technologies. (2020, March 6). shortuuid. Retrieved May 18, 2021, from 
https://github.com/stochastic-technologies/shortuuid/ (Original work published January 
8, 2011)
  
The Biopython Contributors. (2020, May 25). biopython. Retrieved May 18, 2021, from 
https://biopython.org/ (Original work published April 28, 2009)
  
The Python Cryptographic Authority developers. (2020, August 16). bcrypt. Retrieved 
May 18, 2021, from https://github.com/pyca/bcrypt/ (Original work published May 11, 
2013)
  
Tom McCarthy. (2020, June 21). checksumdir. Retrieved May 18, 2021, from 
http://github.com/cakepietoast/checksumdir (Original work published March 4, 2015)
(Unknown). (2020, September 24). toolz. Retrieved May 18, 2021, from 
https://github.com/pytoolz/toolz/ (Original work published September 11, 2013)  
V.A. Traag. (2020, September 23). leidenalg. Retrieved May 18, 2021, from 
https://github.com/vtraag/leidenalg (Original work published October 23, 2018)
127
  
Valentin LAB. (2017, November 19). colour. Retrieved May 18, 2021, from 
http://github.com/vaab/colour (Original work published April 14, 2013)
Willighagen LG. 2019. Citation.js: a format-independent, modular bibliography tool for 
the browser and command line. PeerJ Computer Science 5:e214 
https://doi.org/10.7717/peerj-cs.214 
Yiming Yang, Bo Li. (2020, July 26). harmony-pytorch. Retrieved May 18, 2021, from 
https://github.com/lilab-bcb/harmony-pytorch (Original work published January 16, 
2020)
128
